<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Aging (Albany NY)</journal-id><journal-id journal-id-type="iso-abbrev">Aging (Albany NY)</journal-id><journal-id journal-id-type="publisher-id">Aging</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Aging (Albany NY)</journal-title></journal-title-group><issn pub-type="epub">1945-4589</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28070018</article-id><article-id pub-id-type="pmc">5310664</article-id><article-id pub-id-type="publisher-id">101149</article-id><article-id pub-id-type="doi">10.18632/aging.101149</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Santos-Parker</surname><given-names>Jessica R.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Strahler</surname><given-names>Talia R.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bassett</surname><given-names>Candace J.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bispham</surname><given-names>Nina Z.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chonchol</surname><given-names>Michel B.</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Seals</surname><given-names>Douglas R.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib></contrib-group><aff id="A1"><sup>1</sup> Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA</aff><aff id="A2"><sup>2</sup> Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO 80045, USA</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Douglas R. Seals; <email>seals@colorado.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>1</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>3</day><month>1</month><year>2017</year></pub-date><volume>9</volume><issue>1</issue><fpage>187</fpage><lpage>205</lpage><history><date date-type="received"><day>29</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2017 Santos-Parker et al.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>We hypothesized that curcumin would improve resistance and conduit artery endothelial function and large elastic artery stiffness in healthy middle-aged and older adults. Thirty-nine healthy men and postmenopausal women (45-74 yrs) were randomized to 12 weeks of curcumin (2000 mg/day Longvida&#x000ae;; n=20) or placebo (n=19) supplementation. Forearm blood flow response to acetylcholine infusions (FBF<sub>ACh</sub>; resistance artery endothelial function) increased 37% following curcumin supplementation (107&#x000b1;13 vs. 84&#x000b1;11 AUC at baseline, P=0.03), but not placebo (P=0.2). Curcumin treatment augmented the acute reduction in FBF<sub>ACh</sub> induced by the nitric oxide synthase inhibitor <italic>NG</italic> monomethyl-L-arginine (L-NMMA; P=0.03), and reduced the acute increase in FBF<sub>ACh</sub> to the antioxidant vitamin C (P=0.02), whereas placebo had no effect (both P&#x0003e;0.6). Similarly, brachial artery flow-mediated dilation (conduit artery endothelial function) increased 36% in the curcumin group (5.7&#x000b1;0.4 vs. 4.4&#x000b1;0.4% at baseline, P=0.001), with no change in placebo (P=0.1). Neither curcumin nor placebo influenced large elastic artery stiffness (aortic pulse wave velocity or carotid artery compliance) or circulating biomarkers of oxidative stress and inflammation (all P&#x0003e;0.1). In healthy middle-aged and older adults, 12 weeks of curcumin supplementation improves resistance artery endothelial function by increasing vascular nitric oxide bioavailability and reducing oxidative stress, while also improving conduit artery endothelial function.</p></abstract><kwd-group><kwd>aging</kwd><kwd>curcumin</kwd><kwd>endothelium-dependent dilation</kwd><kwd>arterial stiffness</kwd><kwd>oxidative stress</kwd><kwd>inflammation</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>INTRODUCTION</title><p>Cardiovascular diseases (CVD) are the primary cause of death in developed societies [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>]. Advancing age is the major risk factor for CVD, with a &#x0223c;70% prevalence of CVD in men and women over 60 years of age [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. This increase in CVD risk with aging is due primarily to adverse changes to arteries, in particular, the development of vascular endothelial dysfunction and increased stiffness of large elastic arteries [<xref rid="R4" ref-type="bibr">4</xref>].</p><p>Both resistance artery (microvascular) and conduit artery (macrovascular) endothelial function, as measured by endothelium-dependent dilation (EDD), decline with advancing age [<xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref>] and each is independently predictive of future risk of cardiovascular events and mortality [<xref rid="R12" ref-type="bibr">12</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref>]. Vascular endothelial dysfunction with age appears to develop first in resistance vessels and subsequently in the conduit arteries [<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. A key mechanism mediating the development of age-related endothelial dysfunction is reduced bioavailability of the vascular protective and vasodilatory molecule, nitric oxide [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref>]. Decreased nitric oxide bioavailability with age is in part driven by the presence of oxidative stress, an increase in reactive oxygen species relative to antioxidant defenses, and chronic low-grade inflammation [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R20" ref-type="bibr">20</xref>&#x02013;<xref rid="R22" ref-type="bibr">22</xref>].</p><p>Stiffness of large elastic arteries (aorta and carotid arteries) is commonly assessed regionally and locally by aortic pulse wave velocity (PWV) and carotid artery compliance, respectively [<xref rid="R23" ref-type="bibr">23</xref>, <xref rid="R24" ref-type="bibr">24</xref>]. Large elastic arteries stiffen with advancing age [<xref rid="R25" ref-type="bibr">25</xref>&#x02013;<xref rid="R28" ref-type="bibr">28</xref>], which is associated with a higher risk of cardiovascular-related mortality [<xref rid="R29" ref-type="bibr">29</xref>&#x02013;<xref rid="R31" ref-type="bibr">31</xref>]. Changes in vascular smooth muscle tone and structural components of the arterial wall are thought to be the predominate factors contributing to the increase in stiffness [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R33" ref-type="bibr">33</xref>], driven by reductions in nitric oxide bioavailability and increases in oxidative stress and inflammation [<xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref>]. With the number of older adults in the United States expected to double by the year 2050 [<xref rid="R37" ref-type="bibr">37</xref>], interventions that improve age-related vascular endothelial dysfunction and arterial stiffness are needed to reduce the risk of CVD in this growing population.</p><p>Curcumin is a naturally occurring phenol found in the Indian spice turmeric. Curcumin has been reported to increase nitric oxide production and reduce oxidative stress and inflammation in cell and animal models of vascular-related disease [<xref rid="R38" ref-type="bibr">38</xref>&#x02013;<xref rid="R46" ref-type="bibr">46</xref>], as well as healthy and diseased human populations [<xref rid="R47" ref-type="bibr">47</xref>&#x02013;<xref rid="R50" ref-type="bibr">50</xref>]. In a recent preclinical study from our laboratory [<xref rid="R51" ref-type="bibr">51</xref>], we demonstrated that 4 weeks of curcumin supplementation improved conduit artery endothelial function in older male mice to levels of young animals, mediated by an increase in nitric oxide bioavailability and a reduction in vascular oxidative stress. In addition, curcumin supplementation ameliorated aortic stiffening, as indicated by reductions in aortic PWV to that of young</p><p>adult mice. Taken together, these data suggest that curcumin supplementation holds promise as a treatment strategy for age-related arterial dysfunction.</p><p>The purpose of this study was to translate our preclinical findings in older mice to healthy middle-aged and older adults. We hypothesized that curcumin supplementation would improve age-related vascular endothelial function in middle-aged and older men and postmenopausal women by increasing nitric oxide bioavailability secondary to a reduction in oxidative stress, while also improving large elastic artery stiffness and, possibly, markers of systemic inflammation. To test this hypothesis, we performed a double-blind, parallel design, randomized study in which thirty-nine participants received curcumin (2000 mg/day Longvida&#x000ae; pill) or placebo supplementation for 12 weeks. Resistance artery EDD in the absence and presence of intact nitric oxide production and oxidative stress was assessed, along with conduit artery EDD, large elastic artery stiffness, and circulating markers of oxidative stress and inflammation.</p></sec><sec id="s2"><title>RESULTS</title><sec id="s2_1"><title>Participants</title><p>One hundred and eighteen participants were consented for the study. Fifty-seven individuals did not meet inclusion criteria. Seventeen individuals withdrew from the study prior to randomization due to the time commitment (n=6), study restrictions (n=2), procedure invasiveness (n=1), or did not respond to scheduling requests (n=8). Twenty-one participants were randomized to the placebo group and twenty-three participants to the curcumin group. Two placebo group participants did not complete the study (excluded n=1, side effects: gastrointestinal discomfort; withdrew n=1, time commitment). Two curcumin group participants did not complete the study (excluded n=1, side effects: dizziness; withdrew n=1, non-study related medical concerns) and one participant was excluded from analysis due to a change in exercise status (Figure <xref ref-type="fig" rid="F1">1</xref>). Completed participants were of non-Hispanic Caucasian (n=32), non-Hispanic Asian (n=3), Hispanic Caucasian (n=2), non-Hispanic African American (n=1), or non-Hispanic American Indian/Alaskan (n=1) ethnicity.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Participant progress through study.</p></caption><graphic xlink:href="aging-09-0187-g001"/></fig></sec><sec id="s2_2"><title>Participant characteristics</title><p>All participant characteristics (sex, age, body mass index, waist to hip ratio, body fat percent, blood pressure, heart rate, maximal oxygen consumption, physical activity energy expenditure, lipids, glucose, C-reactive protein) were not different between the placebo and curcumin groups at baseline (all P&#x0003e;0.3), except for body mass, which was higher in the placebo group (P=0.03). Participants were sedentary or moderately physically active. No participant characteristics changed with time between groups (all P&#x0003e;0.05; Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Participant characteristics</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="left" valign="top" colspan="1"/><th colspan="2" align="center" valign="top" rowspan="1">Placebo</th><th colspan="2" align="center" valign="top" rowspan="1">Curcumin</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Week 0</th><th align="center" valign="top" rowspan="1" colspan="1">Week 12</th><th align="center" valign="top" rowspan="1" colspan="1">Week 0</th><th align="center" valign="top" rowspan="1" colspan="1">Week 12</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">N, men/women</td><td align="center" valign="top" rowspan="1" colspan="1">11/8</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">10/10</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="center" valign="top" rowspan="1" colspan="1">61&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">63&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass, kg</td><td align="center" valign="top" rowspan="1" colspan="1">76&#x000b1;3<xref ref-type="table-fn" rid="tfn_002">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">75&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">68&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">68&#x000b1;3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup></td><td align="center" valign="top" rowspan="1" colspan="1">25&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">25&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">24&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">24&#x000b1;1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Waist to hip ratio, U<xref ref-type="table-fn" rid="tfn_001"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.81&#x000b1;0.05</td><td align="center" valign="top" rowspan="1" colspan="1">0.85&#x000b1;0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.84&#x000b1;0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.84&#x000b1;0.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body fat, %</td><td align="center" valign="top" rowspan="1" colspan="1">27.9&#x000b1;2.0</td><td align="center" valign="top" rowspan="1" colspan="1">27.8&#x000b1;2.0</td><td align="center" valign="top" rowspan="1" colspan="1">30.1&#x000b1;1.9</td><td align="center" valign="top" rowspan="1" colspan="1">30.2&#x000b1;1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Systolic blood pressure, mmHg</td><td align="center" valign="top" rowspan="1" colspan="1">120&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">122&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">121&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">121&#x000b1;3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diastolic blood pressure, mmHg</td><td align="center" valign="top" rowspan="1" colspan="1">73&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">73&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">72&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">71&#x000b1;1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Resting heart rate, beats/min<xref ref-type="table-fn" rid="tfn_001"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">56&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">55&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">55&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">57&#x000b1;2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> max, mL/kg/min</td><td align="center" valign="top" rowspan="1" colspan="1">33&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">33&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">31&#x000b1;1</td><td align="center" valign="top" rowspan="1" colspan="1">31&#x000b1;1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Physical activity energy expenditure, kcal/wk<xref ref-type="table-fn" rid="tfn_001"><sup>L</sup></xref></td><td align="center" valign="middle" rowspan="1" colspan="1">6095&#x000b1;872</td><td align="center" valign="middle" rowspan="1" colspan="1">5334&#x000b1;819</td><td align="center" valign="middle" rowspan="1" colspan="1">5720&#x000b1;954</td><td align="center" valign="middle" rowspan="1" colspan="1">5416&#x000b1;984</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total cholesterol, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">177&#x000b1;6</td><td align="center" valign="top" rowspan="1" colspan="1">173&#x000b1;6</td><td align="center" valign="top" rowspan="1" colspan="1">175&#x000b1;8</td><td align="center" valign="top" rowspan="1" colspan="1">174&#x000b1;6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL-cholesterol, mg/dL<xref ref-type="table-fn" rid="tfn_001"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">56&#x000b1;4</td><td align="center" valign="top" rowspan="1" colspan="1">52&#x000b1;4</td><td align="center" valign="top" rowspan="1" colspan="1">55&#x000b1;5</td><td align="center" valign="top" rowspan="1" colspan="1">56&#x000b1;4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL-cholesterol, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">103&#x000b1;6</td><td align="center" valign="top" rowspan="1" colspan="1">102&#x000b1;6</td><td align="center" valign="top" rowspan="1" colspan="1">103&#x000b1;7</td><td align="center" valign="top" rowspan="1" colspan="1">101&#x000b1;6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Triglycerides, mg/dL<xref ref-type="table-fn" rid="tfn_001"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">97&#x000b1;15</td><td align="center" valign="top" rowspan="1" colspan="1">93&#x000b1;15</td><td align="center" valign="top" rowspan="1" colspan="1">86&#x000b1;11</td><td align="center" valign="top" rowspan="1" colspan="1">91&#x000b1;12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glucose, mg/dL</td><td align="center" valign="top" rowspan="1" colspan="1">84&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">85&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">85&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">87&#x000b1;2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C-reactive protein, mg/L<xref ref-type="table-fn" rid="tfn_001"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.96&#x000b1;0.26</td><td align="center" valign="top" rowspan="1" colspan="1">1.15&#x000b1;0.34</td><td align="center" valign="top" rowspan="1" colspan="1">0.81&#x000b1;0.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.72&#x000b1;0.12</td></tr></tbody></table><table-wrap-foot><p>Data are mean&#x000b1;SE; HDL, high-density lipoprotein; LDL, low-density lipoprotein;</p><fn id="tfn_001"><label>L</label><p>Data log transformed for statistical analysis;</p></fn><fn id="tfn_002"><label>*</label><p>P=0.03 vs. curcumin week 0</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2_3"><title>Circulating humoral factors</title><p>Circulating humoral factors were assessed in a subset of participants (placebo n=11-12, curcumin n=13-14) and are presented in <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 1</xref>. All circulating blood factors (interleukin-6: IL-6, tumor necrosis factor-&#x003b1;: TNF-&#x003b1;, oxidized low-density lipoprotein: oxidized LDL, total antioxidant status: TAS, glutathione peroxidase, epinephrine, norepinephrine, endothelin-1, cortisol, adiponectin, leptin, insulin, and homeostasis model assessment of insulin resistance: HOMA-IR) were not different between the placebo and curcumin groups at baseline (all P&#x0003e;0.1), except for free fatty acids, which were lower in the placebo group (P=0.03). No circulating humoral factors changed with time between groups (all P&#x0003e;0.1).</p></sec><sec id="s2_4"><title>Curcumin safety and tolerability</title><p>72% of participants did not miss any intervention pills. Of the 11 participants who missed pills, 5 participants were in the curcumin group and missed a total of 4 to 12 pills throughout the intervention. No severe or unexpected adverse events occurred and the 2000 mg/day Longvida&#x000ae; formulation was well tolerated. Three curcumin group participants experienced &#x0201c;expected&#x0201d; adverse events, including diarrhea (n=1), dizziness (n=1), and gastrointestinal discomfort (n=1). The participant experiencing dizziness was excluded from the study. Four placebo group participants also experienced adverse events, including gastrointestinal discomfort (n=2), diarrhea (n=1), and nausea (n=1). The placebo group participant who experienced gastrointestinal discomfort was excluded from the study (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Safety and tolerability</title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">Placebo</th><th align="center" valign="top" rowspan="1" colspan="1">Curcumin</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment-related adverse events, N</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Diarrhea</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Dizziness</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gastrointestinal discomfort</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Nausea</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Subjects with &#x02265; 1 adverse event, n</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Excluded, N</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr></tbody></table></table-wrap></sec><sec id="s2_5"><title>Dietary analysis</title><p>Total daily energy, relative carbohydrate, and relative fat intake were not different between the placebo and curcumin groups at baseline (all P&#x0003e;0.3) except for daily relative protein intake, which was slightly higher in the placebo group (P=0.02). No dietary intake factors changed with time between the placebo and curcumin groups (all P&#x0003e;0.05; <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 2</xref>).</p></sec><sec id="s2_6"><title>Resistance artery endothelial function</title><p>Forearm blood flow response to incremental intrabrachial artery infusion of acetylcholine (FBF<sub>ACh</sub>) was assessed as a measure of resistance artery endothelial function in a subset of participants (n=12 per group) due to difficulty placing intra-arterial lines in all participants both before and after the intervention period. FBF<sub>ACh</sub> area under the dose-response curve (AUC) was not different between the placebo and curcumin groups at baseline (P=0.3). FBF<sub>ACh</sub> AUC had a group by time interaction between the placebo and curcumin supplementation groups (P=0.02). FBF<sub>ACh</sub> AUC increased 37% after 12 weeks of curcumin supplementation (P=0.03), whereas there was no change with placebo (P=0.2; Figure <xref ref-type="fig" rid="F2">2</xref>). Individual FBF<sub>ACh</sub> AUC at baseline and week 12 for each group are presented in <xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 1</xref>. FBF<sub>ACh</sub> AUC was higher after 12 weeks of curcumin vs. baseline in 9 of the 12 participants treated with curcumin compared with only 2 of the 12 placebo group participants. No sex differences in FBF<sub>ACh</sub> AUC in the curcumin-supplemented group were observed (P=0.2). Resistance artery endothelium-independent dilation, a measure of vascular smooth muscle sensitivity to nitric oxide assessed as the increase in FBF in response to the nitric oxide donor sodium nitroprusside (FBF<sub>SNP</sub>), was not different between the placebo and curcumin groups at baseline (P=0.5) and did not change with time between groups (P=0.9; Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Forearm blood flow (FBF) in response to increasing doses (<italic>left and middle</italic>) and area under the dose-response curve (AUC; <italic>right</italic>) to acetylcholine (FBF<sub>ACh</sub>) at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean &#x000b1; SE; FAV, forearm volume; Group by time P=0.02, *P=0.03 vs. curcumin week 0.</p></caption><graphic xlink:href="aging-09-0187-g002"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Forearm blood flow (FBF) in response to increasing doses (<italic>left and middle</italic>) and area under the dose-response curve (AUC; <italic>right</italic>) to sodium nitroprusside (FBF<sub>SNP</sub>) at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean&#x000b1;SE; FAV, forearm volume; Group by time P=0.9.</p></caption><graphic xlink:href="aging-09-0187-g003"/></fig></sec><sec id="s2_7"><title>Resistance artery nitric oxide-mediated endothelial function</title><p>As shown in Figure <xref ref-type="fig" rid="F4">4</xref> left, in the placebo group there were similar reductions in FBF<sub>ACh</sub> AUC with co-infusion of the nitric oxide synthase inhibitor NG monomethyl-L-arginine (L-NMMA) at week 0 and week 12 (both P=0.002). In contrast, in the curcumin-treated group, reduction in FBF<sub>ACh</sub> with L-NMMA at week 12 following curcumin supplementation (P=0.001) was more significant than that observed at week 0 (P=0.08). To illustrate the effect of curcumin supplementation on the contribution of nitric oxide to improvements in FBF<sub>ACh</sub>, nitric oxide-dependent dilation was calculated as FBF<sub>ACh</sub> with L-NMMA - FBF<sub>ACh</sub> (&#x00394;AUC) and presented as positive values in Figure <xref ref-type="fig" rid="F4">4</xref> right. There was a distinct group by time interaction between the placebo and curcumin supplementation groups (P=0.04). Specifically, 12 weeks of curcumin supplementation increased nitric-oxide dependent dilation (P=0.03), whereas no change was observed in the placebo group (P=0.7).</p><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Forearm blood flow (FBF) area under the dose-response curve (AUC) in response to acetylcholine (FBF<sub>ACh</sub>) without (&#x02212;) or with (+) <italic>NG</italic> monomethyl-L-arginine (L-NMMA; <italic>left</italic>) and nitric oxide-dependent dilation (<italic>right</italic>) at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean&#x000b1;SE; *P&#x0003c;0.02 vs. corresponding group week FBF<sub>ACh</sub> (<italic>left</italic>); Group by time P=0.04, *P=0.03 vs. curcumin week 0 <italic>(right</italic>).</p></caption><graphic xlink:href="aging-09-0187-g004"/></fig></sec><sec id="s2_8"><title>Resistance artery oxidative stress-mediated suppression of endothelial function</title><p>Co-infusion of the antioxidant vitamin C increased FBF<sub>ACh</sub> in both groups at baseline (both P&#x0003c;0.05), demonstrating a tonic oxidative stress-mediated suppression of resistance artery endothelial function. At 12 weeks, co-infusion of vitamin C did not improve FBF<sub>ACh</sub> in the curcumin-supplemented group (P=0.3), but did improve FBF<sub>ACh</sub> in the placebo group (P=0.03; Figure <xref ref-type="fig" rid="F5">5</xref> left). To illustrate the influence of curcumin supplementation, oxidative stress-mediated suppression of EDD was calculated as FBF<sub>ACh</sub> with vitamin C &#x02212; FBF<sub>ACh</sub> (&#x00394;AUC) and presented in Figure <xref ref-type="fig" rid="F5">5</xref> right. A group by time interaction between the placebo and curcumin supplementation groups was observed (P=0.03). Specifically, 12 weeks of curcumin supplementation reduced oxidative stress suppression of EDD (P=0.02), whereas no change was observed in the placebo group (P=0.6).</p><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Forearm blood flow (FBF) area under the dose-response curve (AUC) in response to acetylcholine (FBF<sub>ACh</sub>) without (&#x02212;) or with (+) vitamin C (vitC; <italic>left</italic>) and oxidative stress-mediated suppression of endothelium-dependent dilation (EDD; <italic>right</italic>) at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean&#x000b1;SE; *P&#x0003c;0.05 vs. corresponding group week FBF<sub>ACh</sub> (<italic>left</italic>); Group by time P=0.03, *P=0.02 vs. curcumin week 0 <italic>(right</italic>).</p></caption><graphic xlink:href="aging-09-0187-g005"/></fig></sec><sec id="s2_9"><title>Conduit artery endothelial function</title><p>No group differences in brachial artery flow-mediated dilation (FMD; Figure <xref ref-type="fig" rid="F6">6</xref>), a measure of conduit artery EDD, or parameters (Table <xref ref-type="table" rid="T3">3</xref>) were observed at baseline (all P&#x0003e;0.05). A group by time interaction was observed in brachial artery FMD percent (P=0.001) and absolute (P=0.001) change in which 12 weeks of curcumin supplementation increased brachial artery FMD 36% (P=0.001) with no changes in the placebo group (P=0.8; Figure <xref ref-type="fig" rid="F6">6</xref>; Table <xref ref-type="table" rid="T3">3</xref>). Individual brachial artery FMD at baseline, week 4, and week 12 for each group is presented in <xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 2</xref>. Brachial artery FMD was higher after 12 weeks of curcumin vs. base-line in 17 of the 20 subjects treated with curcumin compared with only 8 of the 19 placebo group subjects. A strong trend for an improvement in FMD was observed at 4 weeks in the curcumin group (P=0.09), but not in the placebo group (P=0.2). Brachial artery dilation to nitroglycerin, a measure of conduit artery endothelium-independent dilation, was assessed in a subset of participants (placebo n=9, curcumin n=6) due to safety restrictions in administering nitroglycerin to individuals with low blood pressure or history of migraines. There were no significant effects of treatment on brachial artery dilation to nitroglycerin (P=0.8; Figure <xref ref-type="fig" rid="F7">7</xref>). In the curcumin-supplemented group, a sex by time interaction in brachial artery FMD was observed at 12 weeks (P=0.001), with significant improvements in both sexes (week 12 vs. baseline: men P=0.001, women P=0.01), but a greater magnitude of improvement in men compared with women (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 3</xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Brachial artery parameters</title></caption><table frame="box" rules="all"><thead><tr><th rowspan="2" align="center" valign="top" colspan="1"/><th colspan="3" align="center" valign="top" rowspan="1">Placebo</th><th colspan="3" align="center" valign="top" rowspan="1">Curcumin</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Week 0</th><th align="center" valign="top" rowspan="1" colspan="1">Week 4</th><th align="center" valign="top" rowspan="1" colspan="1">Week 12</th><th align="center" valign="top" rowspan="1" colspan="1">Week 0</th><th align="center" valign="top" rowspan="1" colspan="1">Week 4</th><th align="center" valign="top" rowspan="1" colspan="1">Week 12</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Baseline diameter, mm</td><td align="center" valign="top" rowspan="1" colspan="1">3.77&#x000b1;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">3.76&#x000b1;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">3.76&#x000b1;0.17</td><td align="center" valign="top" rowspan="1" colspan="1">3.40&#x000b1;0.14</td><td align="center" valign="top" rowspan="1" colspan="1">3.42&#x000b1;0.15</td><td align="center" valign="top" rowspan="1" colspan="1">3.38&#x000b1;0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FMD absolute change, mm</td><td align="center" valign="top" rowspan="1" colspan="1">0.14&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.13&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.14&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.14&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.16&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.19&#x000b1;0.02<xref ref-type="table-fn" rid="tfn_005">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Peak diameter, mm</td><td align="center" valign="top" rowspan="1" colspan="1">3.90&#x000b1;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">3.89&#x000b1;0.18</td><td align="center" valign="top" rowspan="1" colspan="1">3.90&#x000b1;0.17</td><td align="center" valign="top" rowspan="1" colspan="1">3.54&#x000b1;0.13</td><td align="center" valign="top" rowspan="1" colspan="1">3.58&#x000b1;0.15</td><td align="center" valign="top" rowspan="1" colspan="1">3.56&#x000b1;0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Time to peak diameter, s<xref ref-type="table-fn" rid="tfn_004"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">38&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">38&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">37&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">40&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">41&#x000b1;4</td><td align="center" valign="top" rowspan="1" colspan="1">40&#x000b1;3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FMD shear rate, s<sup>&#x02212;1</sup><xref ref-type="table-fn" rid="tfn_004"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">1885&#x000b1;149</td><td align="center" valign="top" rowspan="1" colspan="1">1816&#x000b1;190</td><td align="center" valign="top" rowspan="1" colspan="1">1908&#x000b1;183</td><td align="center" valign="top" rowspan="1" colspan="1">1977&#x000b1;166</td><td align="center" valign="top" rowspan="1" colspan="1">2056&#x000b1;177</td><td align="center" valign="top" rowspan="1" colspan="1">2150&#x000b1;170</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nitroglycerin dilation, mm<xref ref-type="table-fn" rid="tfn_003"><sup>#</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.79&#x000b1;0.05</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">0.77&#x000b1;0.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.77&#x000b1;0.10</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">0.78&#x000b1;0.08</td></tr></tbody></table><table-wrap-foot><p>Data are mean&#x000b1;SE; FMD, flow-mediated dilation;</p><fn id="tfn_003"><label>#</label><p>Placebo, n=9, curcumin, n=6;</p></fn><fn id="tfn_004"><label>L</label><p>Data log transformed for statistical analysis; Group by time P=0.001</p></fn><fn id="tfn_005"><label>*</label><p>P=0.001 vs. curcumin week 0</p></fn></table-wrap-foot></table-wrap><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Brachial artery flow-mediated dilation (FMD) expressed as percent change at week 0 and after 4 and 12 weeks of placebo or curcumin supplementation. Data are mean&#x000b1;SE; Group by time P=0.001, *P=0.001 vs. curcumin week 0.</p></caption><graphic xlink:href="aging-09-0187-g006"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Brachial artery dilation to nitroglycerin expressed as percent change at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean&#x000b1;SE; Group by time P=0.8.</p></caption><graphic xlink:href="aging-09-0187-g007"/></fig></sec><sec id="s2_10"><title>Arterial stiffness</title><p>There were no baseline group differences in aortic PWV, carotid artery compliance (Figure <xref ref-type="fig" rid="F8">8</xref>), or other arterial stiffness parameters (all P&#x0003e;0.1; Table <xref ref-type="table" rid="T4">4</xref>), except for change in carotid artery diameter, which was lower in the placebo group (P=0.02). There was no group by time interaction for aortic PWV (P=0.8), carotid artery compliance (P=0.2), or other arterial stiffness parameters (all P&#x0003e;0.2). No sex-differences in aortic PWV or carotid artery compliance in the curcumin-supplemented group were observed (both P&#x0003e;0.3).</p><fig id="F8" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Aortic pulse wave velocity (PWV; <italic>left</italic>) and carotid artery compliance (<italic>right</italic>) at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean&#x000b1;SE; Data log transformed for statistical analysis; Both group by time P&#x0003e;0.2.</p></caption><graphic xlink:href="aging-09-0187-g008"/></fig><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Arterial stiffness parameters</title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="top" rowspan="1">Placebo</th><th colspan="2" align="center" valign="top" rowspan="1">Curcumin</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">Week 0</th><th align="center" valign="top" rowspan="1" colspan="1">Week 12</th><th align="center" valign="top" rowspan="1" colspan="1">Week 0</th><th align="center" valign="top" rowspan="1" colspan="1">Week 12</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid systolic blood pressure, mmHg</td><td align="center" valign="top" rowspan="1" colspan="1">117&#x000b1;5</td><td align="center" valign="top" rowspan="1" colspan="1">116&#x000b1;5</td><td align="center" valign="top" rowspan="1" colspan="1">123&#x000b1;4</td><td align="center" valign="top" rowspan="1" colspan="1">123&#x000b1;4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid pulse pressure, mmHg</td><td align="center" valign="top" rowspan="1" colspan="1">49&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">48&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">56&#x000b1;4</td><td align="center" valign="top" rowspan="1" colspan="1">56&#x000b1;3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid artery diameter at end-diastole, mm<xref ref-type="table-fn" rid="tfn_006"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">6.35&#x000b1;0.2</td><td align="center" valign="top" rowspan="1" colspan="1">6.35&#x000b1;0.2</td><td align="center" valign="top" rowspan="1" colspan="1">6.41&#x000b1;0.1</td><td align="center" valign="top" rowspan="1" colspan="1">6.38&#x000b1;0.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid change in diameter, mm</td><td align="center" valign="top" rowspan="1" colspan="1">0.35&#x000b1;0.02<xref ref-type="table-fn" rid="tfn_007">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.36&#x000b1;0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.45&#x000b1;0.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.44&#x000b1;0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid augmentation index, %</td><td align="center" valign="top" rowspan="1" colspan="1">16&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">16&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">17&#x000b1;2</td><td align="center" valign="top" rowspan="1" colspan="1">17&#x000b1;2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid &#x003b2;-stiffness index, U</td><td align="center" valign="top" rowspan="1" colspan="1">10.3&#x000b1;0.7</td><td align="center" valign="top" rowspan="1" colspan="1">9.4&#x000b1;0.5</td><td align="center" valign="top" rowspan="1" colspan="1">9.1&#x000b1;0.6</td><td align="center" valign="top" rowspan="1" colspan="1">9.2&#x000b1;0.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid to radial PWV, cm/s</td><td align="center" valign="top" rowspan="1" colspan="1">991&#x000b1;26</td><td align="center" valign="top" rowspan="1" colspan="1">989&#x000b1;34</td><td align="center" valign="top" rowspan="1" colspan="1">945&#x000b1;34</td><td align="center" valign="top" rowspan="1" colspan="1">930&#x000b1;47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Radial augmentation index, %</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;13&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;12&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;8&#x000b1;3</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;6&#x000b1;3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carotid IMT at end diastole, mm<xref ref-type="table-fn" rid="tfn_006"><sup>L</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.56&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.56&#x000b1;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.60&#x000b1;0.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.60&#x000b1;0.02</td></tr></tbody></table><table-wrap-foot><p>Data are mean&#x000b1;SE; PWV, pulse wave velocity; IMT, intima-media thickness;</p><fn id="tfn_006"><label>L</label><p>Data log transformed for statistical analysis;</p></fn><fn id="tfn_007"><label>*</label><p>P=0.02 vs. curcumin week 0</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>DISCUSSION</title><p>This is the first study in humans to assess the beneficial effects of curcumin supplementation on resistance and conduit artery endothelial function, regional and local large elastic artery stiffness, and the mechanisms involved. The present findings demonstrate that 12 weeks of curcumin supplementation is safe and well tolerated, and improves resistance and conduit artery endothelial function in healthy middle-aged and older adults. Improvements in both vascular beds were endothelium specific, as no changes in endothelium-independent dilation were observed. As assessed in resistance vessels, the improvements in endothelial function were mediated by an increase in nitric oxide bioavailability and a reduction in vascular oxidative stress. No changes in regional or local large elastic artery stiffness or circulating biomarkers of oxidative stress and inflammation were observed after 12 weeks of curcumin supplementation.</p><sec id="s3_1"><title>Curcumin supplementation and vascular endothelial function</title><p>Resistance and conduit artery nitric oxide-mediated endothelial function declines with advancing age [<xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref>], with resistance artery dysfunction believed to precede conduit artery impairments [<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Measures of resistance and conduit artery endothelial function, FBF<sub>ACh</sub> and brachial artery FMD, respectively, are each independently predictive of future risk of a cardio-vascular event or mortality [<xref rid="R12" ref-type="bibr">12</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref>], although not necessarily correlated to one another [<xref rid="R52" ref-type="bibr">52</xref>]. When considered along with differences between conduit and resistance vessel structure and function [<xref rid="R53" ref-type="bibr">53</xref>], this suggests that each vascular bed may have relevance to different aspects of CVD and emphasizes the importance of assessing both the resistance and conduit vasculature health.</p><sec id="s3_1_1"><title>Resistance artery function, nitric oxide bioavailability, and oxidative stress</title><p>To our knowledge, no studies have assessed the effects of curcumin supplementation on resistance artery endothelial function in the context of primary aging in preclinical models or humans. In rodent models of diabetes and hypertension, beneficial effects of curcumin on resistance artery endothelial function have been reported in the heart, brain, and eye [<xref rid="R54" ref-type="bibr">54</xref>&#x02013;<xref rid="R56" ref-type="bibr">56</xref>]. In the current study, we show that 12 weeks of oral curcumin supplementation improves resistance artery endothelial function in healthy middle-aged and older men and postmenopausal women. These improvements in FBF<sub>ACh</sub> were endothelium specific, as no changes in FBF<sub>SNP</sub> were observed. 12 weeks of curcumin supplementation enhanced the acute reduction in FBF<sub>ACh</sub> induced by co-infusion with the nitric oxide synthase inhibitor L-NMMA, indicating that improve-ments in resistance artery endothelial function were mediated by an increase in nitric oxide bioavailability.</p><p>In our recent preclinical study [<xref rid="R51" ref-type="bibr">51</xref>], improvements in <italic>ex vivo</italic> carotid artery EDD with 12 weeks of curcumin supplementation in older mice were associated with reduced oxidative stress, as acute <italic>ex vivo</italic> administration of the superoxide dismutase mimetic, TEMPOL, restored EDD in older non-supplemented mice but had no effect on EDD in older curcumin-supplemented mice. Consistent with these observations, in the present study 12 weeks of curcumin supplementation reduced oxidative-stress mediated suppression of resistance artery endothelial function, as evidenced by the smaller improvement in the FBF<sub>ACh</sub> in response to co-infusion of the antioxidant vitamin C following curcumin supplementation. Taken together, these observations indicate that a reduction in vascular oxidative stress was a key mechanism underlying improvements in nitric oxide-mediated resistance artery endothelial function after 12 weeks of curcumin supplementation in our healthy middle-aged and older participants.</p></sec><sec id="s3_1_2"><title>Conduit artery function</title><p>Curcumin is reported to protect against or improve conduit artery endothelial dysfunction in animal models of cardio-metabolic disease, including diabetes, hypertension, and metabolic syndrome [<xref rid="R45" ref-type="bibr">45</xref>, <xref rid="R46" ref-type="bibr">46</xref>, <xref rid="R57" ref-type="bibr">57</xref>, <xref rid="R58" ref-type="bibr">58</xref>]. However, research assessing the effects of curcumin on age-related conduit artery endothelial dysfunction has been limited.</p><p>A preclinical study performed by our laboratory [<xref rid="R51" ref-type="bibr">51</xref>] demonstrated that 4 weeks of curcumin-supplemented chow restored nitric oxide-mediated <italic>ex vivo</italic> carotid EDD in older (26-28 months) male mice to levels of young (4-6 months), with no effect in young mice. In humans, 8 weeks of curcumin supplementation improved brachial artery FMD in healthy Japanese postmenopausal women [<xref rid="R59" ref-type="bibr">59</xref>], similar to a new report in young adults [<xref rid="R60" ref-type="bibr">60</xref>].</p><p>In agreement with these findings, we found that 12 weeks of curcumin supplementation improved brachial artery FMD in healthy middle-aged and older men and postmenopausal women. We are the first to measure conduit artery endothelium-independent dilation with curcumin supplementation in humans and determine that these improvements in conduit artery EDD were endothelium specific, as no changes in brachial artery smooth muscle sensitivity to nitric oxide were observed. Additionally, we observed sex-differences in brachial artery FMD responsiveness to curcumin supplementation. Specifically, both men and women had significant improvements but the magnitude of improvement was greater in men compared with postmenopausal women. These latter observations are consistent with recent findings from our laboratory and others that changes in conduit artery endothelial function with interventions may be affected by sex [<xref rid="R61" ref-type="bibr">61</xref>&#x02013;<xref rid="R65" ref-type="bibr">65</xref>]. Taken together, these data suggest that curcumin may be a promising therapeutic option to improve age-related vascular endothelial function in middle-aged and older adults.</p></sec></sec><sec id="s3_2"><title>Curcumin supplementation and large elastic artery stiffness</title><p>Stiffening of the large elastic arteries with age is attributed to a combination of functional and structural wall changes [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R33" ref-type="bibr">33</xref>]. Arterial functional changes result primarily from increased vascular smooth muscle tone whereas structural wall changes are a consequence of extracellular matrix remodeling, including increased deposition of the load-bearing protein collagen and cross-linking proteins (advanced glycation end products), as well as a reduction and fragmentation of the elasticity conferring protein elastin [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R34" ref-type="bibr">34</xref>].</p><p>A recent preclinical study by our laboratory [<xref rid="R51" ref-type="bibr">51</xref>] demonstrated that 4 weeks of curcumin supplementation reversed age-related large elastic artery stiffness (decreased aortic PWV) in mice and that these improvements were associated with reduced collagen and advanced glycation end products in the aorta. In healthy Japanese postmenopausal women, Akazawa et al. [<xref rid="R66" ref-type="bibr">66</xref>] reported that 8 weeks of curcumin supplementation improved carotid artery compliance. In contrast, despite improvements in vascular endothelial function, in the present study no changes were observed in regional or local large elastic artery stiffness (aortic PWV or carotid artery compliance, respectively) after 12 weeks of curcumin supplementation in healthy middle-aged and older men and postmenopausal women. Analysis of potential sex differences indicated no improvements in postmenopausal women in the curcumin-supplemented group. Differences in carotid artery compliance outcomes between our study and that of Akazawa et al. [<xref rid="R66" ref-type="bibr">66</xref>] may be due to the reduction in carotid systolic blood pressure observed in the latter investigation, explaining the increase in carotid artery compliance but no significant change in &#x003b2;-stiffness, a blood pressure independent index of arterial stiffness [<xref rid="R67" ref-type="bibr">67</xref>]. In the present study we did not observe any changes in carotid systolic blood pressure with 12 weeks of curcumin supplementation. Differences in the subject populations studied&#x02014;middle-aged and older men and women (mostly Caucasian) vs. postmeno-pausal Japanese women&#x02014;also may have contributed.</p><p>Our findings here are consistent with those of several reports suggesting little or no effect of several weeks to months of nutraceutical-based treatment on large elastic artery stiffness in healthy middle-aged and older adults [<xref rid="R68" ref-type="bibr">68</xref>&#x02013;<xref rid="R73" ref-type="bibr">73</xref>], including studies concurrently demonstrating improvements in vascular endothelial function in response to the same treatment [<xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>]. Other studies, however, have reported improvements in arterial stiffness with nutraceutical interventions [<xref rid="R66" ref-type="bibr">66</xref>, <xref rid="R76" ref-type="bibr">76</xref>, <xref rid="R77" ref-type="bibr">77</xref>]. In some cases, these investigations have shown improve-ments in measures such as carotid artery compliance in the absence of changes in aortic pulse wave velocity (aortic stiffness) [<xref rid="R78" ref-type="bibr">78</xref>]. In other instances, aortic stiffness-lowering effects have been reported with longer intervention periods [<xref rid="R79" ref-type="bibr">79</xref>]. Lack of improvements in arterial stiffness in studies showing increases in endothelial function may be due to differences in the mechanisms determining those respective vascular functions. Both are influenced by vasodilatory factors (e.g., nitric oxide) [<xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R80" ref-type="bibr">80</xref>], but arterial stiffness is determined to a greater extent by the composition of structural proteins in the arterial wall [<xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R81" ref-type="bibr">81</xref>]. Structural changes may require a longer treatment period or a different type of intervention (e.g., a stimulus that alters intravascular hemodynamics). Differences in responsiveness between human and animal studies of nutrient-based interventions could be due to a number of factors, including differences in variation of genetic background, metabolism, length of intervention relative to lifespan, and environmental factors.</p></sec><sec id="s3_3"><title>Curcumin supplementation and markers of systemic oxidative stress and inflammation</title><p>Cell culture and preclinical studies have demonstrated that curcumin has antioxidant and anti-inflammatory properties [<xref rid="R38" ref-type="bibr">38</xref>&#x02013;<xref rid="R46" ref-type="bibr">46</xref>]. However, in the present study, no change was observed in circulating markers of oxidative stress (oxidized LDL, TAS, glutathione peroxidase) and inflammation (C-reactive protein, IL-6, TNF-&#x003b1;) with 12 weeks of curcumin supplementation. Although studies in humans evaluating the impact of curcumin supplementation on systemic markers of oxidative stress and inflammation are limited, 4 to 6 weeks of curcumin has been reported to reduce or have no effect on such circulating markers in healthy adults [<xref rid="R48" ref-type="bibr">48</xref>, <xref rid="R82" ref-type="bibr">82</xref>]. Moreover, these circulating markers are not consistently altered in intervention studies that improve vascular endothelial function in healthy middle-aged and older adults [<xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R78" ref-type="bibr">78</xref>, <xref rid="R83" ref-type="bibr">83</xref>]. The lack of change can be attributed to the relatively low levels of systemic oxidative stress and inflammation that, although typically are greater than levels in healthy young adults, are modest compared with patients with chronic diseases, such as overt CVD [<xref rid="R84" ref-type="bibr">84</xref>, <xref rid="R85" ref-type="bibr">85</xref>]. Importantly, recent studies suggest that circulating biomarkers may not be reflective of the local vascular endothelial state in healthy older adults [<xref rid="R86" ref-type="bibr">86</xref>, <xref rid="R87" ref-type="bibr">87</xref>]. As such, the observed reduction in vascular oxidative stress, demonstrated by reduced improvement in EDD with vitamin C infusion following curcumin supplementation, provides the most relevant insight regarding the mechanism of action and endothelium-specific antioxidant effects of curcumin supplementation.</p></sec><sec id="s3_4"><title>Limitations</title><p>To our knowledge there are no acute <italic>in vivo</italic> assessments of pro-inflammatory-mediated suppression of vascular endothelial function as there are for oxidative stress-mediated suppression of endothelial function using vitamin C infusion. The multiple-day administration of salsalate, a nuclear factor &#x003ba;B-inhibiting compound [<xref rid="R88" ref-type="bibr">88</xref>], is challenging and not feasible to administer before and after a chronic intervention. Therefore, we are unable to determine if a reduction in pro-inflammatory vascular signaling contributes to improvements in EDD with curcumin supplementation.</p><p>Caution should be taken in generalizing the present findings to other supplements containing curcumin or dietary consumption of curcumin, due to the differences in formulations between supplements and the varying absorption/bioavailability of curcumin from other sources. Using the same formulation as our study, Gota et al. [<xref rid="R89" ref-type="bibr">89</xref>] demonstrated that circulating curcumin was detectable one hour after consumption of 650 mg Longvida&#x000ae; and peaked at two hours, whereas curcumin was not detectable in the blood following consumption of unformulated curcuminoid extract (&#x0003e;60% curcumin).</p><p>Lastly, we studied primarily healthy Caucasian men and women in the present trial. It remains to be determined whether curcumin supplementation improves vascular function in healthy adults of other ethnicities or in individuals with more severe baseline arterial dysfunction due to the presence of major risk factors for CVD or clinically diagnosed CVD.</p></sec><sec id="s3_5"><title>Conclusions and perspectives</title><p>In healthy middle-aged and older men and postmenopausal women, 12 weeks of curcumin supplementation is well tolerated, and improves resistance and conduit artery endothelial function. Improvement in resistance artery endothelial function is mediated by increases in nitric oxide bioavailability and reductions in vascular oxidative stress. In contrast, curcumin supplementation did not influence large elastic artery stiffness or circulating biomarkers of oxidative stress or inflammation in our sample of late middle-aged and older healthy adults.</p><p>Our findings provide evidence for curcumin supplementation as a promising nutraceutical-based treatment for improving nitric oxide-mediated vascular endothelial function and oxidative stress. As such, curcumin is a nutraceutical that may be helpful for maintaining a healthy vascular endothelium with aging, a key process in preventing the development of athero-sclerosis and attendant arterial diseases. For example, in the present study 12 weeks of curcumin supplementation improved conduit artery endothelial function by 1.3% brachial FMD units in healthy middle-aged and older adults, and a 1% improvement in brachial artery FMD units has been associated with a 13% reduction in risk of future cardiovascular outcomes [<xref rid="R90" ref-type="bibr">90</xref>]. Similarly, amongst hypertensive individuals, those with higher FBF<sub>ACh</sub> have a lower incidence of cardiovascular events in the future, suggesting that improved FBF<sub>ACh</sub> with curcumin may reduce future CVD [<xref rid="R91" ref-type="bibr">91</xref>]. However, additional studies are needed to determine the long-term benefits of curcumin in healthy adults, and to examine the efficacy of curcumin supplementation in individuals with CVD or major risk factors for cardiovascular disorders.</p></sec></sec><sec sec-type="methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4_1"><title>Ethics statement</title><p>Investigation has been conducted in accordance with the ethical standards and according to the Declaration of Helsinki and national and international guidelines. All procedures were reviewed and approved by the Institutional Review Board at the University of Colorado Boulder. The nature, risks, and benefits of all study procedures were explained to volunteers and their written informed consent was obtained before participation in the study. This study was registered on <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> (NCT01968564).</p></sec><sec id="s4_2"><title>Participants</title><p>Thirty-nine healthy men and postmenopausal women aged 45 to 74 years from Boulder County, Colorado and the surrounding areas were studied. All participants were non-smokers and free of clinical diseases, including peripheral arterial disease (ankle-brachial index &#x0003e;0.90), as determined by medical history, physical examination, blood chemistries, and blood pressure and electrocardiogram at rest and during incremental treadmill exercise. All postmenopausal women were amenorrheic &#x02265;1 year and postmenopausal women &#x02264;56 years of age had a follicular stimulating hormone concentration &#x02265;40 IU/L. Participants demonstrated age-related conduit artery endothelial dysfunction at screening, defined as brachial artery FMD &#x0003c;7%.</p></sec><sec id="s4_3"><title>Measurements</title><p>All measurements were performed at the University of Colorado Boulder Clinical Translational Research Center (CTRC) after a &#x0003e;12-hour fast (water allowed) from food, caffeine, and dietary supplements, and &#x0003e;24-hour refrainment from alcohol, physical activity, and prescription medications [<xref rid="R92" ref-type="bibr">92</xref>]. A single, blinded, investigator performed all primary data acquisition and analysis.</p></sec><sec id="s4_4"><title>Participant characteristics</title><p>Body mass index and waist and hip circumferences were determined by anthropometry [<xref rid="R93" ref-type="bibr">93</xref>]. Percent body fat was measured using dual-energy X-ray absorptionmetry (DEXA; GE Lunar Prodigy Advance). Arterial systolic and diastolic blood pressures were assessed in triplicate over the brachial artery at rest with a semi-automated device (Dinamap XL, Johnson &#x00026; Johnson). Maximal oxygen consumption (VO<sub>2</sub> max) was measured during incremental treadmill exercise testing performed to exhaustion (Balke protocol) using open circuit spirometry, as previously described [<xref rid="R94" ref-type="bibr">94</xref>]. Physical activity energy expenditure per week was determined by the Community Healthy Activities Model Program for Seniors questionnaire [<xref rid="R95" ref-type="bibr">95</xref>].</p></sec><sec id="s4_5"><title>Circulating humoral factors</title><p>All blood samples were drawn from an intravenous catheter at the cubital vein. The Colorado Clinical and Translational Sciences Institute CTRC Core Laboratory and Boulder Community Hospital Clinical Laboratory performed all blood assays, as previously described [<xref rid="R78" ref-type="bibr">78</xref>]. Fasting serum lipids were determined with standard assays. Fasting plasma glucose was measured by reflective spectrophotometry (Ortho Clinical Diagnostics) and fasting plasma insulin and serum adiponectin and leptin by radioimmunoassay (Millipore). HOMA-IR was calculated as [fasting plasma glucose (mg/dL) &#x000d7; fasting plasma insulin (&#x003bc;U/mL)]/405 [<xref rid="R96" ref-type="bibr">96</xref>]. Serum follicular stimulating hormone was determined by chemiluminescence (Ortho Clinical Diagnostics). Serum high-sensitivity C-reactive protein was measured by immunoturbidimetry (Beckman Coulter). Serum IL-6 and TNF-&#x003b1; (R&#x00026;D Systems), and plasma oxidized LDL were assessed by ELISA (Mercodia). Serum TAS and whole blood glutathione peroxidase were measured by oxidative method (Randox Laboratories). Plasma epinephrine and norepinephrine were assessed by high performance liquid chromatography (BioRad) and plasma endothelin-1 (Peninsula Labs) by radioimmunoassay. Serum cortisol was determined by a one-step competitive assay (Beckman Coulter) and serum free fatty acids by enzymatic methods (Wako Chemicals USA).</p></sec><sec id="s4_6"><title>Curcumin administration, safety, and tolerability</title><p>Participants were randomized to placebo or curcumin supplementation for 12 weeks in a double-blind manner using a blocked randomization scheme stratified for sex (male vs. female). Placebo or curcumin capsules [2000 mg/day Longvida&#x000ae; (&#x0223c;400 mg curcumin; solid lipid particle formulation)] provided by Verdure Sciences (Noblesville, IN) were taken once every morning while fasted. The Food and Drug Administration categorized curcumin as a supplement for the administration utilized in this study. Every two weeks of the intervention, in-person check-in visits were performed to exchange intervention capsules (precise number of pills were allocated until the participant's next visit) and to assess participant adherence by survey and pill count. Tolerability and side effects were monitored at two-week check-in visits with adverse events documented by the CTRC staff and reported to the Institutional Review Board.</p></sec><sec id="s4_7"><title>Dietary analysis</title><p>Participants were instructed by the CTRC Boulder registered dietitian to maintain their current caloric intake and avoid foods high in curcumin throughout the intervention. Average daily dietary intake was estimated by three-day diet records at baseline and week 12, and participants repeated the same diet the day prior to all experimental visits. Diet records were analyzed by the CTRC Boulder registered dietitian using Nutrition Data System for Research.</p></sec><sec id="s4_8"><title>Resistance artery endothelial function</title><p>Resistance artery EDD and endothelium-independent dilation were determined as FBF<sub>ACh</sub> (1, 2, 4, and 8 &#x003bc;g/100 mL forearm volume/min for 3.5-4 minutes per dose; Bausch and Lomb) and FBF<sub>SNP</sub> (0.5, 1, and 2 &#x003bc;g/100 mL forearm volume/min for 3.5-4 minutes per dose; Marathon Pharmaceuticals LLC), respectively, using strain gauge venous occlusion plethysmography (A16 Arterial Inflow System, D.E. Hokanson) as previously described [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R97" ref-type="bibr">97</xref>]. To assess resistance artery nitric oxide-mediated EDD, FBF<sub>ACh</sub> in the absence and presence of the nitric oxide synthase inhibitor, L-NMMA (10 minute loading dose of 5 mg/minute at 2.5 mL/minute and maintenance dose of 1 mg/minute at 0.5 mL/minute; Bachem), was measured. Resistance artery oxidative stress-mediated suppression of EDD was determined by FBF<sub>ACh</sub> in the absence and presence of the antioxidant vitamin C (10 minute loading dose of 25 mg/minute at 2.5 mL/minute and maintenance dose of 25 mg/minute at 0.5 mL/minute; Mylan Institutional LLC). FBF values are reported as individual dose responses and AUC.</p></sec><sec id="s4_9"><title>Conduit artery endothelial function</title><p>Conduit artery EDD and endothelium-independent dilation were determined by brachial artery FMD (using a five-minute forearm cuff) and brachial artery diameter change following 0.4 mg sublingual nitroglycerin, respectively, using high-resolution ultrasonography (Toshiba Xario XG) as previously described [<xref rid="R92" ref-type="bibr">92</xref>, <xref rid="R98" ref-type="bibr">98</xref>, <xref rid="R99" ref-type="bibr">99</xref>]. Brachial artery FMD was measured at baseline, week 4, and week 12, and brachial artery dilation to nitroglycerin at baseline and week 12. Brachial artery FMD and dilation to nitroglycerin are reported as percentage and absolute (mm) change from baseline diameter [<xref rid="R92" ref-type="bibr">92</xref>]. Brachial artery FMD shear rate was calculated as [8 &#x000d7; mean velocity (m/s)]/occlusion diameter (m) [<xref rid="R92" ref-type="bibr">92</xref>]. Brachial artery diameters and blood velocities were captured and analyzed by Vascular Research Tools 5.10.9 (Medical Imaging Applications).</p></sec><sec id="s4_10"><title>Large elastic artery stiffness</title><p>Large elastic artery stiffness was assessed regionally via aortic PWV and locally via carotid artery compliance as previously described [<xref rid="R100" ref-type="bibr">100</xref>]. Briefly, central (aortic: carotid to femoral) and peripheral (carotid to radial) PWV was determined by applanation tonometry with simultaneous electrocardiogram gating of the R-wave to measure the time delay between the foot of the carotid and femoral or radial arterial pressure waves and augmentation index was measured by applanation tonometry of the common carotid or radial artery (Non-Invasive Hemodynamics Workstation, Cardiovascular Engineering Inc.). PWV and augmentation index were calculated by the Non-Invasive Hemodynamics Workstation as the distance between arterial sites (cm) divided by the arterial pressure wave transit time at each site (s), and the &#x00394;pressure (mmHg) divided by the pulse pressure (mmHg) &#x000d7; 100, respectively [<xref rid="R100" ref-type="bibr">100</xref>].</p><p>Carotid artery compliance was assessed using ultrasonography (Toshiba Xario XG) to measure arterial diameter from end-systole to end-diastole while simultaneously measuring carotid arterial pressure changes via applanation tonometry as previously described [<xref rid="R24" ref-type="bibr">24</xref>]. Carotid artery compliance was calculated as {3.141592 &#x000d7; 2 &#x000d7; carotid diastolic diameter (mm) &#x000d7; [carotid systolic &#x02212; diastolic diameter (mm)] + [carotid systolic &#x02212; diastolic diameter (mm)]<sup>2</sup>}/[4 &#x000d7; carotid pulse pressure (mmHg)] [<xref rid="R101" ref-type="bibr">101</xref>] and &#x003b2;-stiffness as Ln[carotid systolic blood pressure (mmHg)/carotid diastolic blood pressure (mmHg)]/{[carotid systolic diameter &#x02212; carotid diastolic diameter (mm)]/carotid diastolic diameter (mm)} [<xref rid="R67" ref-type="bibr">67</xref>]. Carotid artery diameters were captured and analyzed by Vascular Research Tools 5.10.9 (Medical Imaging Applications).</p></sec><sec id="s4_11"><title>Data analysis</title><p>Statistical analysis was performed with IBM SPSS 23 and G*Power 3.1. Data normality was assessed with the Shapiro-Wilk test and non-normal variables were log base 10 transformed for statistical analysis. Outliers (&#x02265;3 standard deviations) were replaced with the group mean. An independent t-test was performed to assess group differences at baseline. A mixed-model ANOVA was performed to identify group (curcumin vs. placebo) by time [week 0, (4), and 12] interactions for all primary outcomes and clinical characteristics. To determine if there were sex-differences in the curcumin group after 12 weeks of supplementation, a mixed-model ANOVA was performed to identify any sex (men vs. women) by time interactions for all primary outcomes. In the case of a significant effect of curcumin supplementation on FBF<sub>ACh</sub>, a mixed-model ANOVA was performed to identify group by time interactions for nitric oxide (via L-NMMA) and oxidative stress (via vitamin C)-mediated EDD. In the case of significant interactions, a paired t-test was performed for within-group comparisons with Bonferroni correction. The acute effects on FBF<sub>ACh</sub> with co-infusion of L-NMMA and vitamin C were assessed by paired t-tests with Bonferroni correction. Sample size was estimated based on our laboratory's previous lifestyle intervention studies, using the primary outcome with the lowest effect size (FBF<sub>ACh</sub>: 0.7) to detect significant group differences [<xref rid="R83" ref-type="bibr">83</xref>, <xref rid="R102" ref-type="bibr">102</xref>&#x02013;<xref rid="R104" ref-type="bibr">104</xref>]. Data are expressed as mean&#x000b1;standard error (SE). Statistical significance was set at &#x003b1;&#x0003c;0.05.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>SUPPLEMENTARY MATERIAL TABLES</title><supplementary-material content-type="local-data" id="SD1"><media mimetype="application" mime-subtype="pdf" xlink:href="aging-09-0187-s001.pdf" orientation="portrait" xlink:type="simple" id="d35e1635" position="anchor"/></supplementary-material></sec></body><back><ack><p>The authors thank Bradley Fleenor for his pre-study technical support and Hannah Van Ark, Sierra Hill, Molly McNamara, and the staff of the University of Colorado Boulder Clinical and Translational Research Center for their technical assistance.</p></ack><fn-group><fn fn-type="con"><p><bold>AUTHOR CONTRIBUTIONS</bold></p><p>Initial study design [JSP, DRS], vascular data acquisition/analysis [JSP, TRS, NZB], data interpretation [JSP, DRS], creating tables/figures [JSP], writing initial draft [JSP], editing and approving final draft [JSP, TRS, CJB, NZB, MBC, DRS].</p></fn><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST</bold></p><p>The authors have no declarations of interest to disclose.</p></fn><fn fn-type="supported-by"><p><bold>FUNDING</bold></p><p>This work was supported by National Institutes of Health awards R21 AG042795, Colorado CTSA UL1 TR001082, T32 AG000279-14S1, R37 AG013038-17S1, and R21 AG042795-01A1S1. Contents are the authors' sole responsibility and do not necessarily represent official National Institutes of Health views.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lonn</surname><given-names>E</given-names></name><name><surname>Bosch</surname><given-names>J</given-names></name><name><surname>Teo</surname><given-names>KK</given-names></name><name><surname>Pais</surname><given-names>P</given-names></name><name><surname>Xavier</surname><given-names>D</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name></person-group><article-title>The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions</article-title><source>Circulation</source><year>2010</year><volume>122</volume><fpage>2078</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.873232</pub-id><pub-id pub-id-type="pmid">21098469</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>WS</given-names></name><name><surname>Daniels</surname><given-names>SR</given-names></name><name><surname>Burke</surname><given-names>LE</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name><name><surname>Hayman</surname><given-names>LL</given-names></name><name><surname>Lloyd-Jones</surname><given-names>D</given-names></name><name><surname>Pandey</surname><given-names>DK</given-names></name><name><surname>Sanchez</surname><given-names>EJ</given-names></name><name><surname>Schram</surname><given-names>AP</given-names></name><name><surname>Whitsel</surname><given-names>LP</given-names></name><collab>American Heart Association Advocacy Coordinating Committee, and Council on Cardiovascular Disease in the Young, and Council on the Kidney in Cardiovascular Disease, and Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing, and Council on Arteriosclerosis, and Thrombosis and Vascular Biology, and Council on Clinical Cardiology, and Stroke Council</collab></person-group><article-title>Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association</article-title><source>Circulation</source><year>2011</year><volume>124</volume><fpage>967</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e3182285a81</pub-id><pub-id pub-id-type="pmid">21788592</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Blaha</surname><given-names>MJ</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Das</surname><given-names>SR</given-names></name><name><surname>de Ferranti</surname><given-names>S</given-names></name><name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name><name><surname>Fullerton</surname><given-names>HJ</given-names></name><name><surname>Howard</surname><given-names>VJ</given-names></name><name><surname>Huffman</surname><given-names>MD</given-names></name><name><surname>Isasi</surname><given-names>CR</given-names></name><etal/><collab>Writing Group Members, and American Heart Association Statistics Committee, and Stroke Statistics Subcommittee</collab></person-group><article-title>Heart disease and stroke statistics-2016 update: a report from the American Heart Association</article-title><source>Circulation</source><year>2016</year><volume>133</volume><fpage>e38</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000350</pub-id><pub-id pub-id-type="pmid">26673558</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a &#x0201c;set up&#x0201d; for vascular disease</article-title><source>Circulation</source><year>2003</year><volume>107</volume><fpage>139</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000048892.83521.58</pub-id><pub-id pub-id-type="pmid">12515756</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Sorensen</surname><given-names>KE</given-names></name><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Georgakopoulos</surname><given-names>D</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name></person-group><article-title>Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women</article-title><source>J Am Coll Cardiol</source><year>1994</year><volume>24</volume><fpage>471</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(94)90305-0</pub-id><pub-id pub-id-type="pmid">8034885</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSouza</surname><given-names>CA</given-names></name><name><surname>Shapiro</surname><given-names>LF</given-names></name><name><surname>Clevenger</surname><given-names>CM</given-names></name><name><surname>Dinenno</surname><given-names>FA</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>1351</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.102.12.1351</pub-id><pub-id pub-id-type="pmid">10993851</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>AJ</given-names></name><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Silver</surname><given-names>AE</given-names></name><name><surname>Levy</surname><given-names>AS</given-names></name><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Gates</surname><given-names>PE</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB</article-title><source>Circ Res</source><year>2007</year><volume>100</volume><fpage>1659</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000269183.13937.e8</pub-id><pub-id pub-id-type="pmid">17478731</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Robinson</surname><given-names>JA</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing</article-title><source>J Physiol</source><year>2004</year><volume>556</volume><fpage>315</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.057042</pub-id><pub-id pub-id-type="pmid">14754992</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Mattei</surname><given-names>P</given-names></name><name><surname>Sudano</surname><given-names>I</given-names></name><name><surname>Bernini</surname><given-names>G</given-names></name><name><surname>Pinto</surname><given-names>S</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name></person-group><article-title>Menopause is associated with endothelial dysfunction in women</article-title><source>Hypertension</source><year>1996</year><volume>28</volume><fpage>576</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.28.4.576</pub-id><pub-id pub-id-type="pmid">8843881</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Salvetti</surname><given-names>G</given-names></name><name><surname>Bernini</surname><given-names>G</given-names></name><name><surname>Magagna</surname><given-names>A</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name></person-group><article-title>Age-related reduction of NO availability and oxidative stress in humans</article-title><source>Hypertension</source><year>2001</year><volume>38</volume><fpage>274</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.38.2.274</pub-id><pub-id pub-id-type="pmid">11509489</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Mattei</surname><given-names>P</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Gennari</surname><given-names>A</given-names></name><name><surname>Fasolo</surname><given-names>CB</given-names></name><name><surname>Sudano</surname><given-names>I</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name></person-group><article-title>Aging and endothelial function in normotensive subjects and patients with essential hypertension</article-title><source>Circulation</source><year>1995</year><volume>91</volume><fpage>1981</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.91.7.1981</pub-id><pub-id pub-id-type="pmid">7895356</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Berglund</surname><given-names>L</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>Sundstr&#x000f6;m</surname><given-names>J</given-names></name></person-group><article-title>Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease</article-title><source>Circulation</source><year>2011</year><volume>123</volume><fpage>1545</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.984047</pub-id><pub-id pub-id-type="pmid">21444885</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newcomer</surname><given-names>SC</given-names></name><name><surname>Leuenberger</surname><given-names>UA</given-names></name><name><surname>Hogeman</surname><given-names>CS</given-names></name><name><surname>Proctor</surname><given-names>DN</given-names></name></person-group><article-title>Heterogeneous vasodilator responses of human limbs: influence of age and habitual endurance training</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2005</year><volume>289</volume><fpage>H308</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01151.2004</pub-id><pub-id pub-id-type="pmid">15778285</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeboah</surname><given-names>J</given-names></name><name><surname>Crouse</surname><given-names>JR</given-names></name><name><surname>Hsu</surname><given-names>FC</given-names></name><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Herrington</surname><given-names>DM</given-names></name></person-group><article-title>Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>2390</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.678276</pub-id><pub-id pub-id-type="pmid">17452608</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeboah</surname><given-names>J</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Polak</surname><given-names>JF</given-names></name><name><surname>Post</surname><given-names>W</given-names></name><name><surname>Lima</surname><given-names>JA</given-names></name><name><surname>Crouse</surname><given-names>JR</given-names></name><name><surname>Herrington</surname><given-names>DM</given-names></name></person-group><article-title>Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis</article-title><source>Circulation</source><year>2009</year><volume>120</volume><fpage>502</fpage><lpage>09</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.864801</pub-id><pub-id pub-id-type="pmid">19635967</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutterman</surname><given-names>DD</given-names></name><name><surname>Chabowski</surname><given-names>DS</given-names></name><name><surname>Kadlec</surname><given-names>AO</given-names></name><name><surname>Durand</surname><given-names>MJ</given-names></name><name><surname>Freed</surname><given-names>JK</given-names></name><name><surname>Ait-Aissa</surname><given-names>K</given-names></name><name><surname>Beyer</surname><given-names>AM</given-names></name></person-group><article-title>The human microcirculation: regulation of flow and beyond</article-title><source>Circ Res</source><year>2016</year><volume>118</volume><fpage>157</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.305364</pub-id><pub-id pub-id-type="pmid">26837746</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>Jablonski</surname><given-names>KL</given-names></name><name><surname>Donato</surname><given-names>AJ</given-names></name></person-group><article-title>Aging and vascular endothelial function in humans</article-title><source>Clin Sci (Lond)</source><year>2011</year><volume>120</volume><fpage>357</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1042/CS20100476</pub-id><pub-id pub-id-type="pmid">21244363</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Galetta</surname><given-names>F</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Salvetti</surname><given-names>G</given-names></name><name><surname>Franzoni</surname><given-names>F</given-names></name><name><surname>Giusti</surname><given-names>C</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name></person-group><article-title>Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes</article-title><source>Circulation</source><year>2000</year><volume>101</volume><fpage>2896</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.25.2896</pub-id><pub-id pub-id-type="pmid">10869260</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>AJ</given-names></name><name><surname>Morgan</surname><given-names>RG</given-names></name><name><surname>Walker</surname><given-names>AE</given-names></name><name><surname>Lesniewski</surname><given-names>LA</given-names></name></person-group><article-title>Cellular and molecular biology of aging endothelial cells</article-title><source>J Mol Cell Cardiol</source><year>2015</year><volume>89</volume><fpage>122</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.01.021</pub-id><pub-id pub-id-type="pmid">25655936</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Valensin</surname><given-names>S</given-names></name><name><surname>Bonaf&#x000e8;</surname><given-names>M</given-names></name><name><surname>Paolisso</surname><given-names>G</given-names></name><name><surname>Yashin</surname><given-names>AI</given-names></name><name><surname>Monti</surname><given-names>D</given-names></name><name><surname>De Benedictis</surname><given-names>G</given-names></name></person-group><article-title>The network and the remodeling theories of aging: historical background and new perspectives</article-title><source>Exp Gerontol</source><year>2000</year><volume>35</volume><fpage>879</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/S0531-5565(00)00172-8</pub-id><pub-id pub-id-type="pmid">11053678</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>AE</given-names></name><name><surname>Kaplon</surname><given-names>RE</given-names></name><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Nowlan</surname><given-names>MJ</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Prevention of age-related endothelial dysfunction by habitual aerobic exercise in healthy humans: possible role of nuclear factor &#x003ba;B</article-title><source>Clin Sci (Lond.)</source><year>2014</year><volume>127</volume><fpage>645</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1042/CS20140030</pub-id><pub-id pub-id-type="pmid">24947434</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandes</surname><given-names>RP</given-names></name><name><surname>Fleming</surname><given-names>I</given-names></name><name><surname>Busse</surname><given-names>R</given-names></name></person-group><article-title>Endothelial aging</article-title><source>Cardiovasc Res</source><year>2005</year><volume>66</volume><fpage>286</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.12.027</pub-id><pub-id pub-id-type="pmid">15820197</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>GF</given-names></name><name><surname>Izzo</surname><given-names>JL</given-names><suffix>Jr</suffix></name><name><surname>Lacourci&#x000e8;re</surname><given-names>Y</given-names></name><name><surname>Ouellet</surname><given-names>JP</given-names></name><name><surname>Neutel</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>C</given-names></name><name><surname>Kerwin</surname><given-names>LJ</given-names></name><name><surname>Block</surname><given-names>AJ</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name></person-group><article-title>Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study</article-title><source>Circulation</source><year>2002</year><volume>105</volume><fpage>2955</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000020500.77568.3C</pub-id><pub-id pub-id-type="pmid">12081987</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Dinenno</surname><given-names>FA</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Clevenger</surname><given-names>CM</given-names></name><name><surname>DeSouza</surname><given-names>CA</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Aging, habitual exercise, and dynamic arterial compliance</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>1270</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.102.11.1270</pub-id><pub-id pub-id-type="pmid">10982542</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name></person-group><article-title>Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging</article-title><source>Hypertension</source><year>2002</year><volume>39</volume><fpage>865</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000014506.13322.66</pub-id><pub-id pub-id-type="pmid">11967241</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>DeSouza</surname><given-names>CA</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Absence of age-related increase in central arterial stiffness in physically active women</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1998</year><volume>18</volume><fpage>127</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.18.1.127</pub-id><pub-id pub-id-type="pmid">9445266</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaitkevicius</surname><given-names>PV</given-names></name><name><surname>Fleg</surname><given-names>JL</given-names></name><name><surname>Engel</surname><given-names>JH</given-names></name><name><surname>O'Connor</surname><given-names>FC</given-names></name><name><surname>Wright</surname><given-names>JG</given-names></name><name><surname>Lakatta</surname><given-names>LE</given-names></name><name><surname>Yin</surname><given-names>FC</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name></person-group><article-title>Effects of age and aerobic capacity on arterial stiffness in healthy adults</article-title><source>Circulation</source><year>1993</year><volume>88</volume><fpage>1456</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.88.4.1456</pub-id><pub-id pub-id-type="pmid">8403292</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>GF</given-names></name><name><surname>Parise</surname><given-names>H</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Keyes</surname><given-names>MJ</given-names></name><name><surname>Vita</surname><given-names>JA</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study</article-title><source>Hypertension</source><year>2004</year><volume>43</volume><fpage>1239</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000128420.01881.aa</pub-id><pub-id pub-id-type="pmid">15123572</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattace-Raso</surname><given-names>FU</given-names></name><name><surname>van der Cammen</surname><given-names>TJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>van Popele</surname><given-names>NM</given-names></name><name><surname>Bos</surname><given-names>ML</given-names></name><name><surname>Schalekamp</surname><given-names>MA</given-names></name><name><surname>Asmar</surname><given-names>R</given-names></name><name><surname>Reneman</surname><given-names>RS</given-names></name><name><surname>Hoeks</surname><given-names>AP</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name></person-group><article-title>Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>657</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.555235</pub-id><pub-id pub-id-type="pmid">16461838</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willum-Hansen</surname><given-names>T</given-names></name><name><surname>Staessen</surname><given-names>JA</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Thijs</surname><given-names>L</given-names></name><name><surname>Ibsen</surname><given-names>H</given-names></name><name><surname>Jeppesen</surname><given-names>J</given-names></name></person-group><article-title>Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>664</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.579342</pub-id><pub-id pub-id-type="pmid">16461839</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Spears</surname><given-names>M</given-names></name><name><surname>Boustred</surname><given-names>C</given-names></name><name><surname>May</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>SG</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Boutouyrie</surname><given-names>P</given-names></name><name><surname>Cameron</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Cruickshank</surname><given-names>JK</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name><etal/></person-group><article-title>Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects</article-title><source>J Am Coll Cardiol</source><year>2014</year><volume>63</volume><fpage>636</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2013.09.063</pub-id><pub-id pub-id-type="pmid">24239664</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease</article-title><source>Circulation</source><year>2003</year><volume>107</volume><fpage>346</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000048893.62841.F7</pub-id><pub-id pub-id-type="pmid">12538439</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najjar</surname><given-names>SS</given-names></name><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name></person-group><article-title>Arterial aging: is it an immutable cardiovascular risk factor?</article-title><source>Hypertension</source><year>2005</year><volume>46</volume><fpage>454</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000177474.06749.98</pub-id><pub-id pub-id-type="pmid">16103272</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleenor</surname><given-names>BS</given-names></name></person-group><article-title>Large elastic artery stiffness with aging: novel translational mechanisms and interventions</article-title><source>Aging Dis</source><year>2012</year><volume>4</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">23696949</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>Moreau</surname><given-names>KL</given-names></name><name><surname>Gates</surname><given-names>PE</given-names></name><name><surname>Eskurza</surname><given-names>I</given-names></name></person-group><article-title>Modulatory influences on ageing of the vasculature in healthy humans</article-title><source>Exp Gerontol</source><year>2006</year><volume>41</volume><fpage>501</fpage><lpage>07</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2006.01.001</pub-id><pub-id pub-id-type="pmid">16537099</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwald</surname><given-names>SE</given-names></name></person-group><article-title>Ageing of the conduit arteries</article-title><source>J Pathol</source><year>2007</year><volume>211</volume><fpage>157</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/path.2101</pub-id><pub-id pub-id-type="pmid">17200940</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Bureau</surname><given-names>USC</given-names></name></person-group><year>2008</year><article-title>Population Projections. Table 12. Projections of the populations by age and sex for the United States 2010 to 2050</article-title></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Kim</surname><given-names>CW</given-names></name></person-group><article-title>Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets</article-title><source>Int J Mol Med</source><year>2007</year><volume>19</volume><fpage>469</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">17273796</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Moon</surname><given-names>HI</given-names></name><name><surname>Park</surname><given-names>WH</given-names></name></person-group><article-title>Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism</article-title><source>J Enzyme Inhib Med Chem</source><year>2010</year><volume>25</volume><fpage>720</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.3109/14756360903555274</pub-id><pub-id pub-id-type="pmid">20163327</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SK</given-names></name><name><surname>Rains</surname><given-names>J</given-names></name><name><surname>Croad</surname><given-names>J</given-names></name><name><surname>Larson</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name></person-group><article-title>Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats</article-title><source>Antioxid Redox Signal</source><year>2009</year><volume>11</volume><fpage>241</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1089/ars.2008.2140</pub-id><pub-id pub-id-type="pmid">18976114</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olszanecki</surname><given-names>R</given-names></name><name><surname>Gebska</surname><given-names>A</given-names></name><name><surname>Korbut</surname><given-names>R</given-names></name></person-group><article-title>The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin</article-title><source>Basic Clin Pharmacol Toxicol</source><year>2007</year><volume>101</volume><fpage>411</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1111/j.1742-7843.2007.00151.x</pub-id><pub-id pub-id-type="pmid">17973899</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balogun</surname><given-names>E</given-names></name><name><surname>Hoque</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Killeen</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>CJ</given-names></name><name><surname>Foresti</surname><given-names>R</given-names></name><name><surname>Alam</surname><given-names>J</given-names></name><name><surname>Motterlini</surname><given-names>R</given-names></name></person-group><article-title>Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element</article-title><source>Biochem J</source><year>2003</year><volume>371</volume><fpage>887</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1042/bj20021619</pub-id><pub-id pub-id-type="pmid">12570874</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coban</surname><given-names>D</given-names></name><name><surname>Milenkovic</surname><given-names>D</given-names></name><name><surname>Chanet</surname><given-names>A</given-names></name><name><surname>Khallou-Laschet</surname><given-names>J</given-names></name><name><surname>Sabbe</surname><given-names>L</given-names></name><name><surname>Palagani</surname><given-names>A</given-names></name><name><surname>Vanden Berghe</surname><given-names>W</given-names></name><name><surname>Mazur</surname><given-names>A</given-names></name><name><surname>Morand</surname><given-names>C</given-names></name></person-group><article-title>Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration</article-title><source>Mol Nutr Food Res</source><year>2012</year><volume>56</volume><fpage>1270</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201100818</pub-id><pub-id pub-id-type="pmid">22753158</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisberg</surname><given-names>SP</given-names></name><name><surname>Leibel</surname><given-names>R</given-names></name><name><surname>Tortoriello</surname><given-names>DV</given-names></name></person-group><article-title>Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity</article-title><source>Endocrinology</source><year>2008</year><volume>149</volume><fpage>3549</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1210/en.2008-0262</pub-id><pub-id pub-id-type="pmid">18403477</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakmareong</surname><given-names>S</given-names></name><name><surname>Kukongviriyapan</surname><given-names>U</given-names></name><name><surname>Pakdeechote</surname><given-names>P</given-names></name><name><surname>Donpunha</surname><given-names>W</given-names></name><name><surname>Kukongviriyapan</surname><given-names>V</given-names></name><name><surname>Kongyingyoes</surname><given-names>B</given-names></name><name><surname>Sompamit</surname><given-names>K</given-names></name><name><surname>Phisalaphong</surname><given-names>C</given-names></name></person-group><article-title>Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2011</year><volume>383</volume><fpage>519</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1007/s00210-011-0624-z</pub-id><pub-id pub-id-type="pmid">21448566</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>XD</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Chen</surname><given-names>YY</given-names></name></person-group><article-title>Curcumin ameliorates high glucose-induced acute vascular endothelial dysfunction in rat thoracic aorta</article-title><source>Clin Exp Pharmacol Physiol</source><year>2009</year><volume>36</volume><fpage>1177</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2009.05210.x</pub-id><pub-id pub-id-type="pmid">19473193</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>KB</given-names></name><name><surname>Kuttan</surname><given-names>R</given-names></name></person-group><article-title>Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers</article-title><source>Indian J Physiol Pharmacol</source><year>1992</year><volume>36</volume><fpage>273</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">1291482</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiSilvestro</surname><given-names>RA</given-names></name><name><surname>Joseph</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Bomser</surname><given-names>J</given-names></name></person-group><article-title>Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people</article-title><source>Nutr J</source><year>2012</year><volume>11</volume><fpage>79</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-11-79</pub-id><pub-id pub-id-type="pmid">23013352</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y</given-names></name><name><surname>Hosseini</surname><given-names>MS</given-names></name><name><surname>Khalili</surname><given-names>N</given-names></name><name><surname>Naimi</surname><given-names>E</given-names></name><name><surname>Majeed</surname><given-names>M</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis</article-title><source>Clin Nutr</source><year>2015</year><volume>34</volume><fpage>1101</fpage><lpage>08</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2014.12.019</pub-id><pub-id pub-id-type="pmid">25618800</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongcharoen</surname><given-names>W</given-names></name><name><surname>Jai-Aue</surname><given-names>S</given-names></name><name><surname>Phrommintikul</surname><given-names>A</given-names></name><name><surname>Nawarawong</surname><given-names>W</given-names></name><name><surname>Woragidpoonpol</surname><given-names>S</given-names></name><name><surname>Tepsuwan</surname><given-names>T</given-names></name><name><surname>Sukonthasarn</surname><given-names>A</given-names></name><name><surname>Apaijai</surname><given-names>N</given-names></name><name><surname>Chattipakorn</surname><given-names>N</given-names></name></person-group><article-title>Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting</article-title><source>Am J Cardiol</source><year>2012</year><volume>110</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2012.02.043</pub-id><pub-id pub-id-type="pmid">22481014</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleenor</surname><given-names>BS</given-names></name><name><surname>Sindler</surname><given-names>AL</given-names></name><name><surname>Marvi</surname><given-names>NK</given-names></name><name><surname>Howell</surname><given-names>KL</given-names></name><name><surname>Zigler</surname><given-names>ML</given-names></name><name><surname>Yoshizawa</surname><given-names>M</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Curcumin ameliorates arterial dysfunction and oxidative stress with aging</article-title><source>Exp Gerontol</source><year>2013</year><volume>48</volume><fpage>269</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2012.10.008</pub-id><pub-id pub-id-type="pmid">23142245</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>DeSouza</surname><given-names>CA</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Pharmacologic versus flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans</article-title><source>Am J Cardiol</source><year>2001</year><volume>88</volume><fpage>1067</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(01)01997-X</pub-id><pub-id pub-id-type="pmid">11704016</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>WW</given-names></name><name><surname>O'Rourke</surname><given-names>MF</given-names></name><name><surname>McDonald</surname><given-names>DA</given-names></name></person-group><year>2005</year><source>McDonald's blood flow in arteries : theoretical, experimental, and clinical principles</source><publisher-loc>London; New York</publisher-loc><publisher-name>Hodder Arnold</publisher-name><comment>Distributed in the U.S.A. by Oxford University Press</comment></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anupunpisit</surname><given-names>V</given-names></name><name><surname>Petpiboolthai</surname><given-names>H</given-names></name><name><surname>Khimmaktong</surname><given-names>W</given-names></name></person-group><article-title>Microvasculature Improvement of Heart in Diabetic Rat with Curcumin Supplementation</article-title><source>J Med Assoc Thai</source><year>2015</year><issue>Suppl 10</issue><volume>98</volume><fpage>S74</fpage><lpage>83</lpage></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>QM</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>ZM</given-names></name></person-group><article-title>The therapeutic effect of curcumin in male albino rats and its putative mechanisms on cerebral microvascular flow</article-title><source>Brain Res</source><year>2016</year><volume>1642</volume><fpage>131</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2016.03.022</pub-id><pub-id pub-id-type="pmid">27017961</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khimmaktong</surname><given-names>W</given-names></name><name><surname>Petpiboolthai</surname><given-names>H</given-names></name><name><surname>Sriya</surname><given-names>P</given-names></name><name><surname>Anupunpisit</surname><given-names>V</given-names></name></person-group><article-title>Effects of curcumin on restoration and improvement of microvasculature characteristic in diabetic rat's choroid of eye</article-title><source>J Med Assoc Thai</source><year>2014</year><issue>Suppl 2</issue><volume>97</volume><fpage>S39</fpage><lpage>46</lpage></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majithiya</surname><given-names>JB</given-names></name><name><surname>Balaraman</surname><given-names>R</given-names></name></person-group><article-title>Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin</article-title><source>J Cardiovasc Pharmacol</source><year>2005</year><volume>46</volume><fpage>697</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1097/01.fjc.0000183720.85014.24</pub-id><pub-id pub-id-type="pmid">16220078</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Bassossy</surname><given-names>HM</given-names></name><name><surname>El-Maraghy</surname><given-names>NN</given-names></name><name><surname>El-Fayoumi</surname><given-names>HM</given-names></name><name><surname>Watson</surname><given-names>ML</given-names></name></person-group><article-title>Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery</article-title><source>Br J Pharmacol</source><year>2009</year><volume>158</volume><fpage>1527</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00419.x</pub-id><pub-id pub-id-type="pmid">19845678</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akazawa</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Miyaki</surname><given-names>A</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Sugawara</surname><given-names>J</given-names></name><name><surname>Ajisaka</surname><given-names>R</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name></person-group><article-title>Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women</article-title><source>Nutr Res</source><year>2012</year><volume>32</volume><fpage>795</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2012.09.002</pub-id><pub-id pub-id-type="pmid">23146777</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>JM</given-names></name><name><surname>Stoner</surname><given-names>L</given-names></name><name><surname>Rowlands</surname><given-names>DS</given-names></name><name><surname>Caldwell</surname><given-names>AR</given-names></name><name><surname>Sanders</surname><given-names>E</given-names></name><name><surname>Kreutzer</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>JB</given-names></name><name><surname>Purpura</surname><given-names>M</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>R</given-names></name></person-group><article-title>Novel form of curcumin improves endothelial function in young, healthy individuals: a double-blind placebo controlled study</article-title><source>J Nutr Metab</source><year>2016</year><volume>2016</volume><fpage>1089653</fpage><pub-id pub-id-type="doi">10.1155/2016/1089653</pub-id><pub-id pub-id-type="pmid">27630772</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Walker</surname><given-names>AE</given-names></name><name><surname>Fay</surname><given-names>TN</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults</article-title><source>Clin Sci (Lond.)</source><year>2011</year><volume>120</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1042/CS20100174</pub-id><pub-id pub-id-type="pmid">20642454</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Parker</surname><given-names>JR</given-names></name><name><surname>LaRocca</surname><given-names>TJ</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Aerobic exercise and other healthy lifestyle factors that influence vascular aging</article-title><source>Adv Physiol Educ</source><year>2014</year><volume>38</volume><fpage>296</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1152/advan.00088.2014</pub-id><pub-id pub-id-type="pmid">25434012</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galetta</surname><given-names>F</given-names></name><name><surname>Franzoni</surname><given-names>F</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Salvetti</surname><given-names>A</given-names></name><name><surname>Santoro</surname><given-names>G</given-names></name></person-group><article-title>Endothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjects</article-title><source>Atherosclerosis</source><year>2006</year><volume>186</volume><fpage>184</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.07.013</pub-id><pub-id pub-id-type="pmid">16102774</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinder</surname><given-names>MR</given-names></name><name><surname>Spina</surname><given-names>RJ</given-names></name><name><surname>Ehsani</surname><given-names>AA</given-names></name></person-group><article-title>Enhanced endothelium-dependent vasodilation in older endurance-trained men</article-title><source>J Appl Physiol</source><year>2000</year><volume>88</volume><fpage>761</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">10658048</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>DP</given-names></name><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Howe</surname><given-names>KS</given-names></name><name><surname>Mering</surname><given-names>MC</given-names></name><name><surname>Braith</surname><given-names>RW</given-names></name></person-group><article-title>Effect of resistance training on arterial wave reflection and brachial artery reactivity in normotensive postmenopausal women</article-title><source>Eur J Appl Physiol</source><year>2007</year><volume>100</volume><fpage>403</fpage><lpage>08</lpage><pub-id pub-id-type="doi">10.1007/s00421-007-0447-2</pub-id><pub-id pub-id-type="pmid">17394009</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akazawa</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Miyaki</surname><given-names>A</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Sugawara</surname><given-names>J</given-names></name><name><surname>Ajisaka</surname><given-names>R</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name></person-group><article-title>Effects of curcumin intake and aerobic exercise training on arterial compliance in postmenopausal women</article-title><source>Artery Res</source><year>2013</year><volume>7</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.artres.2012.09.003</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>T</given-names></name><name><surname>Sasayama</surname><given-names>S</given-names></name><name><surname>Kawasaki</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>S</given-names></name></person-group><article-title>Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis</article-title><source>Circulation</source><year>1989</year><volume>80</volume><fpage>78</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.80.1.78</pub-id><pub-id pub-id-type="pmid">2610739</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gepner</surname><given-names>AD</given-names></name><name><surname>Ramamurthy</surname><given-names>R</given-names></name><name><surname>Krueger</surname><given-names>DC</given-names></name><name><surname>Korcarz</surname><given-names>CE</given-names></name><name><surname>Binkley</surname><given-names>N</given-names></name><name><surname>Stein</surname><given-names>JH</given-names></name></person-group><article-title>A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e36617</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0036617</pub-id><pub-id pub-id-type="pmid">22586483</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Robinson</surname><given-names>JA</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2004</year><volume>286</volume><fpage>H1528</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00879.2003</pub-id><pub-id pub-id-type="pmid">15020306</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soare</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>EP</given-names></name><name><surname>Holloszy</surname><given-names>JO</given-names></name><name><surname>Fontana</surname><given-names>L</given-names></name></person-group><article-title>Multiple dietary supplements do not affect metabolic and cardio-vascular health</article-title><source>Aging (Albany NY)</source><year>2014</year><volume>6</volume><fpage>149</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.18632/aging.100597</pub-id><pub-id pub-id-type="pmid">24659610</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pase</surname><given-names>MP</given-names></name><name><surname>Grima</surname><given-names>NA</given-names></name><name><surname>Sarris</surname><given-names>J</given-names></name></person-group><article-title>The effects of dietary and nutrient interventions on arterial stiffness: a systematic review</article-title><source>Am J Clin Nutr</source><year>2011</year><volume>93</volume><fpage>446</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.3945/ajcn.110.002725</pub-id><pub-id pub-id-type="pmid">21147858</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname><given-names>AH</given-names></name><name><surname>Rehman</surname><given-names>A</given-names></name><name><surname>Wan Yusuf</surname><given-names>WN</given-names></name><name><surname>Rahman</surname><given-names>AR</given-names></name></person-group><article-title>Vitamin E and its effect on arterial stiffness in postmenopausal women&#x02013;a randomized controlled trial</article-title><source>Int J Clin Pharmacol Ther</source><year>2003</year><volume>41</volume><fpage>587</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.5414/CPP41587</pub-id><pub-id pub-id-type="pmid">14692708</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zureik</surname><given-names>M</given-names></name><name><surname>Galan</surname><given-names>P</given-names></name><name><surname>Bertrais</surname><given-names>S</given-names></name><name><surname>Mennen</surname><given-names>L</given-names></name><name><surname>Czernichow</surname><given-names>S</given-names></name><name><surname>Blacher</surname><given-names>J</given-names></name><name><surname>Ducimeti&#x000e8;re</surname><given-names>P</given-names></name><name><surname>Hercberg</surname><given-names>S</given-names></name></person-group><article-title>Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>1485</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000136648.62973.c8</pub-id><pub-id pub-id-type="pmid">15217803</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplon</surname><given-names>RE</given-names></name><name><surname>Hill</surname><given-names>SD</given-names></name><name><surname>Bispham</surname><given-names>NZ</given-names></name><name><surname>Santos-Parker</surname><given-names>JR</given-names></name><name><surname>Nowlan</surname><given-names>MJ</given-names></name><name><surname>Snyder</surname><given-names>LL</given-names></name><name><surname>Chonchol</surname><given-names>M</given-names></name><name><surname>LaRocca</surname><given-names>TJ</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults</article-title><source>Aging (Albany NY)</source><year>2016</year><volume>8</volume><fpage>1167</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.18632/aging.100962</pub-id><pub-id pub-id-type="pmid">27208415</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitalia</surname><given-names>N</given-names></name><name><surname>Ismail</surname><given-names>T</given-names></name><name><surname>Tooth</surname><given-names>L</given-names></name><name><surname>Boa</surname><given-names>F</given-names></name><name><surname>Hampson</surname><given-names>G</given-names></name><name><surname>Goldsmith</surname><given-names>D</given-names></name><name><surname>Kaski</surname><given-names>JC</given-names></name><name><surname>Banerjee</surname><given-names>D</given-names></name></person-group><article-title>Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e91363</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0091363</pub-id><pub-id pub-id-type="pmid">24646518</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mottram</surname><given-names>P</given-names></name><name><surname>Shige</surname><given-names>H</given-names></name><name><surname>Nestel</surname><given-names>P</given-names></name></person-group><article-title>Vitamin E improves arterial compliance in middle-aged men and women</article-title><source>Atherosclerosis</source><year>1999</year><volume>145</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(99)00073-8</pub-id><pub-id pub-id-type="pmid">10488969</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pase</surname><given-names>MP</given-names></name><name><surname>Grima</surname><given-names>N</given-names></name><name><surname>Cockerell</surname><given-names>R</given-names></name><name><surname>Stough</surname><given-names>C</given-names></name><name><surname>Scholey</surname><given-names>A</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name><name><surname>Pipingas</surname><given-names>A</given-names></name></person-group><article-title>The effects of long-chain omega-3 fish oils and multivitamins on cognitive and cardiovascular function: a randomized, controlled clinical trial</article-title><source>J Am Coll Nutr</source><year>2015</year><volume>34</volume><fpage>21</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1080/07315724.2014.880660</pub-id><pub-id pub-id-type="pmid">25565485</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeVan</surname><given-names>AE</given-names></name><name><surname>Johnson</surname><given-names>LC</given-names></name><name><surname>Brooks</surname><given-names>FA</given-names></name><name><surname>Evans</surname><given-names>TD</given-names></name><name><surname>Justice</surname><given-names>JN</given-names></name><name><surname>Cruickshank-Quinn</surname><given-names>C</given-names></name><name><surname>Reisdorph</surname><given-names>N</given-names></name><name><surname>Bryan</surname><given-names>NS</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Santos-Parker</surname><given-names>JR</given-names></name><name><surname>Chonchol</surname><given-names>MB</given-names></name><name><surname>Bassett</surname><given-names>CJ</given-names></name><name><surname>Sindler</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Effects of sodium nitrite supplementation on vascular function and related small metabolite signatures in middle-aged and older adults</article-title><source>J Appl Physiol</source><year>2016</year><volume>120</volume><fpage>416</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00879.2015</pub-id><pub-id pub-id-type="pmid">26607249</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapen</surname><given-names>MH</given-names></name><name><surname>Braam</surname><given-names>LA</given-names></name><name><surname>Drummen</surname><given-names>NE</given-names></name><name><surname>Bekers</surname><given-names>O</given-names></name><name><surname>Hoeks</surname><given-names>AP</given-names></name><name><surname>Vermeer</surname><given-names>C</given-names></name></person-group><article-title>Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial</article-title><source>Thromb Haemost</source><year>2015</year><volume>113</volume><fpage>1135</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1160/TH14-08-0675</pub-id><pub-id pub-id-type="pmid">25694037</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>IB</given-names></name><name><surname>Franklin</surname><given-names>SS</given-names></name><name><surname>Cockcroft</surname><given-names>JR</given-names></name></person-group><article-title>Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology</article-title><source>Hypertension</source><year>2004</year><volume>44</volume><fpage>112</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000138068.03893.40</pub-id><pub-id pub-id-type="pmid">15262901</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsamis</surname><given-names>A</given-names></name><name><surname>Krawiec</surname><given-names>JT</given-names></name><name><surname>Vorp</surname><given-names>DA</given-names></name></person-group><article-title>Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review</article-title><source>J R Soc Interface</source><year>2013</year><volume>10</volume><fpage>20121004</fpage><pub-id pub-id-type="doi">10.1098/rsif.2012.1004</pub-id><pub-id pub-id-type="pmid">23536538</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>KH</given-names></name><name><surname>Pipingas</surname><given-names>A</given-names></name><name><surname>Scholey</surname><given-names>AB</given-names></name></person-group><article-title>Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population</article-title><source>J Psychopharmacol</source><year>2015</year><volume>29</volume><fpage>642</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1177/0269881114552744</pub-id><pub-id pub-id-type="pmid">25277322</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jablonski</surname><given-names>KL</given-names></name><name><surname>Racine</surname><given-names>ML</given-names></name><name><surname>Geolfos</surname><given-names>CJ</given-names></name><name><surname>Gates</surname><given-names>PE</given-names></name><name><surname>Chonchol</surname><given-names>M</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>61</volume><fpage>335</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.09.010</pub-id><pub-id pub-id-type="pmid">23141486</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toshima</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>A</given-names></name><name><surname>Kurabayashi</surname><given-names>M</given-names></name><name><surname>Itabe</surname><given-names>H</given-names></name><name><surname>Takano</surname><given-names>T</given-names></name><name><surname>Sugano</surname><given-names>J</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>J</given-names></name><name><surname>Michishita</surname><given-names>I</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>R</given-names></name></person-group><article-title>Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2000</year><volume>20</volume><fpage>2243</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.20.10.2243</pub-id><pub-id pub-id-type="pmid">11031210</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelmouttaleb</surname><given-names>I</given-names></name><name><surname>Danchin</surname><given-names>N</given-names></name><name><surname>Ilardo</surname><given-names>C</given-names></name><name><surname>Aimone-Gastin</surname><given-names>I</given-names></name><name><surname>Angio&#x000ef;</surname><given-names>M</given-names></name><name><surname>Lozniewski</surname><given-names>A</given-names></name><name><surname>Loubinoux</surname><given-names>J</given-names></name><name><surname>Le Faou</surname><given-names>A</given-names></name><name><surname>Gu&#x000e9;ant</surname><given-names>JL</given-names></name></person-group><article-title>C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes</article-title><source>Am Heart J</source><year>1999</year><volume>137</volume><fpage>346</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1053/hj.1999.v137.92052</pub-id><pub-id pub-id-type="pmid">9924170</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>AJ</given-names></name><name><surname>Black</surname><given-names>AD</given-names></name><name><surname>Jablonski</surname><given-names>KL</given-names></name><name><surname>Gano</surname><given-names>LB</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans</article-title><source>Aging Cell</source><year>2008</year><volume>7</volume><fpage>805</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2008.00438.x</pub-id><pub-id pub-id-type="pmid">18782346</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Donato</surname><given-names>AJ</given-names></name><name><surname>LaRocca</surname><given-names>TJ</given-names></name><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Silver</surname><given-names>AE</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Habitually exercising older men do not demonstrate age-associated vascular endothelial oxidative stress</article-title><source>Aging Cell</source><year>2011</year><volume>10</volume><fpage>1032</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2011.00748.x</pub-id><pub-id pub-id-type="pmid">21943306</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Lesniewski</surname><given-names>LA</given-names></name><name><surname>Lawson</surname><given-names>BR</given-names></name><name><surname>Beske</surname><given-names>SD</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Nuclear factor-kappaB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans</article-title><source>Circulation</source><year>2009</year><volume>119</volume><fpage>1284</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.804294</pub-id><pub-id pub-id-type="pmid">19237660</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gota</surname><given-names>VS</given-names></name><name><surname>Maru</surname><given-names>GB</given-names></name><name><surname>Soni</surname><given-names>TG</given-names></name><name><surname>Gandhi</surname><given-names>TR</given-names></name><name><surname>Kochar</surname><given-names>N</given-names></name><name><surname>Agarwal</surname><given-names>MG</given-names></name></person-group><article-title>Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers</article-title><source>J Agric Food Chem</source><year>2010</year><volume>58</volume><fpage>2095</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1021/jf9024807</pub-id><pub-id pub-id-type="pmid">20092313</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inaba</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>JA</given-names></name><name><surname>Bergmann</surname><given-names>SR</given-names></name></person-group><article-title>Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis</article-title><source>Int J Cardiovasc Imaging</source><year>2010</year><volume>26</volume><fpage>631</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s10554-010-9616-1</pub-id><pub-id pub-id-type="pmid">20339920</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perticone</surname><given-names>F</given-names></name><name><surname>Ceravolo</surname><given-names>R</given-names></name><name><surname>Pujia</surname><given-names>A</given-names></name><name><surname>Ventura</surname><given-names>G</given-names></name><name><surname>Iacopino</surname><given-names>S</given-names></name><name><surname>Scozzafava</surname><given-names>A</given-names></name><name><surname>Ferraro</surname><given-names>A</given-names></name><name><surname>Chello</surname><given-names>M</given-names></name><name><surname>Mastroroberto</surname><given-names>P</given-names></name><name><surname>Verdecchia</surname><given-names>P</given-names></name><name><surname>Schillaci</surname><given-names>G</given-names></name></person-group><article-title>Prognostic significance of endothelial dysfunction in hypertensive patients</article-title><source>Circulation</source><year>2001</year><volume>104</volume><fpage>191</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.104.2.191</pub-id><pub-id pub-id-type="pmid">11447085</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RA</given-names></name><name><surname>Nishiyama</surname><given-names>SK</given-names></name><name><surname>Wray</surname><given-names>DW</given-names></name><name><surname>Richardson</surname><given-names>RS</given-names></name></person-group><article-title>Ultrasound assessment of flow-mediated dilation</article-title><source>Hypertension</source><year>2010</year><volume>55</volume><fpage>1075</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.110.150821</pub-id><pub-id pub-id-type="pmid">20351340</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lohman</surname><given-names>TG</given-names></name><name><surname>R</surname><given-names>A</given-names></name><name><surname>M</surname><given-names>R</given-names></name></person-group><source>Anthropometric standardization reference manual</source><publisher-name>Human Kinetics</publisher-name><year>1988</year></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>SL</given-names></name><name><surname>Davy</surname><given-names>KP</given-names></name><name><surname>Stevenson</surname><given-names>ET</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Physiological determinants of 10-km performance in highly trained female runners of different ages</article-title><source>J Appl Physiol</source><year>1995</year><volume>78</volume><fpage>1931</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">7649932</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>AL</given-names></name><name><surname>Mills</surname><given-names>KM</given-names></name><name><surname>King</surname><given-names>AC</given-names></name><name><surname>Haskell</surname><given-names>WL</given-names></name><name><surname>Gillis</surname><given-names>D</given-names></name><name><surname>Ritter</surname><given-names>PL</given-names></name></person-group><article-title>CHAMPS physical activity questionnaire for older adults: outcomes for interventions</article-title><source>Med Sci Sports Exerc</source><year>2001</year><volume>33</volume><fpage>1126</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1097/00005768-200107000-00010</pub-id><pub-id pub-id-type="pmid">11445760</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><name><surname>Naylor</surname><given-names>BA</given-names></name><name><surname>Treacher</surname><given-names>DF</given-names></name><name><surname>Turner</surname><given-names>RC</given-names></name></person-group><article-title>Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title><source>Diabetologia</source><year>1985</year><volume>28</volume><fpage>412</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1007/BF00280883</pub-id><pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>AJ</given-names></name><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Jablonski</surname><given-names>KL</given-names></name><name><surname>Gano</surname><given-names>LB</given-names></name><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Cytochrome P-450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans</article-title><source>J Appl Physiol</source><year>2008</year><volume>105</volume><fpage>1359</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.90629.2008</pub-id><pub-id pub-id-type="pmid">18669935</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Celermajer</surname><given-names>D</given-names></name><name><surname>Charbonneau</surname><given-names>F</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Deanfield</surname><given-names>J</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name><name><surname>Gerhard-Herman</surname><given-names>M</given-names></name><name><surname>Herrington</surname><given-names>D</given-names></name><name><surname>Vallance</surname><given-names>P</given-names></name><name><surname>Vita</surname><given-names>J</given-names></name><name><surname>Vogel</surname><given-names>R</given-names></name><collab>International Brachial Artery Reactivity Task Force</collab></person-group><article-title>Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force</article-title><source>J Am Coll Cardiol</source><year>2002</year><volume>39</volume><fpage>257</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(01)01746-6</pub-id><pub-id pub-id-type="pmid">11788217</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskurza</surname><given-names>I</given-names></name><name><surname>Myerburgh</surname><given-names>LA</given-names></name><name><surname>Kahn</surname><given-names>ZD</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults</article-title><source>J Physiol</source><year>2005</year><volume>568</volume><fpage>1057</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2005.092734</pub-id><pub-id pub-id-type="pmid">16141271</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>RR</given-names></name><name><surname>Wilkinson</surname><given-names>IB</given-names></name><name><surname>Schiffrin</surname><given-names>EL</given-names></name><name><surname>Avolio</surname><given-names>AP</given-names></name><name><surname>Chirinos</surname><given-names>JA</given-names></name><name><surname>Cockcroft</surname><given-names>JR</given-names></name><name><surname>Heffernan</surname><given-names>KS</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>McEniery</surname><given-names>CM</given-names></name><name><surname>Mitchell</surname><given-names>GF</given-names></name><name><surname>Najjar</surname><given-names>SS</given-names></name><name><surname>Nichols</surname><given-names>WW</given-names></name><name><surname>Urbina</surname><given-names>EM</given-names></name><name><surname>Weber</surname><given-names>T</given-names></name><collab>American Heart Association Council on Hypertension</collab></person-group><article-title>Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association</article-title><source>Hypertension</source><year>2015</year><volume>66</volume><fpage>698</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1161/HYP.0000000000000033</pub-id><pub-id pub-id-type="pmid">26160955</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Bortel</surname><given-names>LM</given-names></name><name><surname>Duprez</surname><given-names>D</given-names></name><name><surname>Starmans-Kool</surname><given-names>MJ</given-names></name><name><surname>Safar</surname><given-names>ME</given-names></name><name><surname>Giannattasio</surname><given-names>C</given-names></name><name><surname>Cockcroft</surname><given-names>J</given-names></name><name><surname>Kaiser</surname><given-names>DR</given-names></name><name><surname>Thuillez</surname><given-names>C</given-names></name></person-group><article-title>Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures</article-title><source>Am J Hypertens</source><year>2002</year><volume>15</volume><fpage>445</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/S0895-7061(01)02326-3</pub-id><pub-id pub-id-type="pmid">12022247</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Beske</surname><given-names>SD</given-names></name><name><surname>Lawson</surname><given-names>BR</given-names></name><name><surname>Southall</surname><given-names>KL</given-names></name><name><surname>Benay</surname><given-names>FJ</given-names></name><name><surname>Donato</surname><given-names>AJ</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults</article-title><source>Hypertension</source><year>2008</year><volume>52</volume><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.111427</pub-id><pub-id pub-id-type="pmid">18504322</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>AE</given-names></name><name><surname>Kaplon</surname><given-names>RE</given-names></name><name><surname>Lucking</surname><given-names>SM</given-names></name><name><surname>Russell-Nowlan</surname><given-names>MJ</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults</article-title><source>Hypertension</source><year>2012</year><volume>60</volume><fpage>1517</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.112.203661</pub-id><pub-id pub-id-type="pmid">23108655</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Clevenger</surname><given-names>CM</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Reiling</surname><given-names>MJ</given-names></name><name><surname>Hiatt</surname><given-names>WR</given-names></name><name><surname>Davy</surname><given-names>KP</given-names></name><name><surname>DeSouza</surname><given-names>CA</given-names></name></person-group><article-title>Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>38</volume><fpage>506</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(01)01348-1</pub-id><pub-id pub-id-type="pmid">11499745</pub-id></element-citation></ref></ref-list></back></article>